FDA Regulation of Electronic Nicotine Delivery Systems and the “Deeming” Rule: What’s Left for States? by Tilburg, William et al.
Journal of Health Care Law and Policy
Volume 20 | Issue 1 Article 3
FDA Regulation of Electronic Nicotine Delivery





Follow this and additional works at: http://digitalcommons.law.umaryland.edu/jhclp
This Article is brought to you for free and open access by the Academic Journals at DigitalCommons@UM Carey Law. It has been accepted for
inclusion in Journal of Health Care Law and Policy by an authorized editor of DigitalCommons@UM Carey Law. For more information, please contact
smccarty@law.umaryland.edu.
Recommended Citation
William Tilburg, Kathleen Hoke, & Mellissa Sager, FDA Regulation of Electronic Nicotine Delivery Systems and the “Deeming” Rule:
What’s Left for States?, 20 J. Health Care L. & Pol'y 27 (2017).
Available at: http://digitalcommons.law.umaryland.edu/jhclp/vol20/iss1/3
 27 
FDA REGULATION OF ELECTRONIC 
NICOTINE DELIVERY SYSTEMS AND 
THE “DEEMING” RULE: WHAT’S 
LEFT FOR STATES? 
WILLIAM TILBURG, KATHLEEN HOKE, & MELLISSA SAGER 
 Beginning August 8, 2016, electronic nicotine delivery systems 
(“ENDS”), commonly referred to as electronic cigarettes or e-
cigarettes, are subject to the authority of the U.S. Food and Drug 
Administration (“FDA”) and regulated as tobacco products under 
federal law. Laws prohibiting sales to minors, requiring ID checks, 
restricting vending machine purchases, and mandating health 
warning labels that currently apply to cigarettes, smokeless tobacco, 
and other “conventional tobacco products” will extend to ENDS. The 
new regulations do not have preemptive effect, meaning state and 
local governments retain authority to enact additional restrictions on 
the distribution, sale, and use of ENDS. At the same time, the 
European Union has embraced ENDS as a safer alternative to 
smoking conventional tobacco products, with laws reflecting that 
policy position.  
 The new regulations provoke the question of whether these devices, 
which aerosolize a liquid nicotine solution that is inhaled in a manner 
similar to conventional smoking, should be subject to the same 
restrictions as conventional tobacco products? ENDS aerosol 
contains toxicants, including known human carcinogens, but at 
significantly lower levels than found in conventional tobacco 
products. And, while the long term health effects associated with 
ENDS are unknown, they are almost certainly less harmful than 
conventional tobacco products. Experimental and observational 
studies also suggest ENDS may be effective smoking cessation tools. 
On the other hand, ENDS use among high school students increased 
tenfold from 2011 to 2015 (4.5% to 44.9%) and a growing body of 
evidence indicates youth ENDS users are significantly more likely to 
initiate use of conventional tobacco products.  
 In light of rising youth use, uncertainty surrounding the long term 
health effects, and potential for helping adult smokers quit, how 
should state and local governments regulate these devices? This 
article will summarize the new fed-                                                              
eral regulations governing ENDS, review scientific studies on the 
health effects and potential cessation benefits associated with ENDS, 
and discuss policy options to reduce youth access and use that do not 
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prevent or unduly burden adult smokers from using ENDS to quit 
smoking.  
I. INTRODUCTION 
Smoking has been the leading cause of preventable death in the United 
States for many decades.1  This list of diseases and other negative health 
consequences caused by smoking is extensive; exposure to secondhand smoke 
creates similar health outcomes.2  As a result, medical and public health 
professionals are naturally concerned about the marketing of any product that 
emulates smoking yet are eager to offer smokers truly effective tools for 
cessation.3  This is why the electronic cigarette creates a conundrum for those 
working to reduce smoking and improve public health. Is this new product as 
bad as its namesake?  Or is it a safe, viable method to achieve cessation? 
 As researchers embarked on the time-consuming and expensive process of 
determining the health effects and cessation potential of electronic cigarettes—
now better terms electronic nicotine delivery systems or ENDS—the product 
exploded in the marketplace. No longer a quirky, expensive mystery device sold 
at mall kiosks, ENDS are becoming ubiquitous, available in cheap disposable 
versions and elaborate, pricey, reusable devices with high-tech options. The 
liquid nicotine market has likewise developed rapidly to offer consumers 
virtually any flavor imaginable and a variety of nicotine levels.4  Specialty vape 
shops now pepper communities. ENDS are advertised in the same media venues 
as cigarettes—magazines and point-of-sale—and where cigarette promotion is 
forbidden—television and radio. Celebrities have touted the benefits of ENDS 
on network television and been seen using the product at major entertainment 
events.5  ENDS are used indoors in places where smoking has long been 
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 1. OFFICE OF THE SURGEON GEN’L, U.S. DEPT OF HEALTH AND HUMAN SERV., THE HEALTH 
CONSEQUENCES OF SMOKING –50 YEARS OF PROGRESS, A REPORT OF THE SURGEON GENERAL, 
EXECUTIVE SUMMARY at iii (2014) (hereinafter “Surgeon General’s Report”), available at 
http://www.surgeongeneral.gov/library/reports/50-years-of-progress/exec-summary.pdf. 
 2. See id. (explaining that active smoking is causally associated with numerous cancer related 
illnesses and other illnesses, and secondhand smoking is causally associated with increased risk of stroke). 
 3. See Carrie Arnold, Vaping and Health: What Do We Know about E-Cigarettes?, 122 ENVTL. 
HEALTH PERSPECTIVES A244, A245–46 (2014), (reporting that, while health professionals believe e-
cigarettes are not harmless, e-cigarettes may be a preferred alternative to smoking). 
 4. Joseph G. Allenet. al., Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and 
Acetoin in a Sample of 51 Products, Including Fruit-, Candy-, and Cocktail-Flavored E-Cigarettes, 
ENVTL. HEALTH PERSPECTIVES, at 3 (Dec. 8, 2015), http://ehp.niehs.nih.gov/wp-
content/uploads/advpub/2015/12/ehp.1510185.acco.pdf (finding that over 7000 flavors of e-cigarettes are 
currently marketed); see Caroline Chen et al., E-Cigarette Design Preference and Smoking Cessation: A 
U.S. Population Study, AM. J. PREVENTATIVE MED. 356, 360 (2016) (explaining that users can choose 
higher strengths of nicotine and many different e-liquid flavors). 
 5. See also Brittney Stephens, 6 Times Leonardo DiCaprio Has Hit the Vape During a Big Event, 
POPSUGAR (Feb. 12, 2016), http://www.popsugar.com/celebrity/Leonardo-DiCaprio-Smoking-Vaping-
Events-40023817#photo-40023817 (describing the overwhelming social media response to an award-
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prohibited. Vaping consumers ardently supports ENDS, both as cessation 
devices and as a product offering the same enjoyment as cigarettes with much 
reduced risk or negative health outcomes.  Within this frenzy, research moves 
forward as best possible. 
 Little is known about the long-term health effects and public health impact 
of ENDS. Preliminary research raises concerns, particularly to a public health 
community still waging a decades-long battle against the original cigarette.  
Policymakers and public health officials are stymied, having to take action and 
engage in public education with a modest amount of research.  Caution has 
prevailed to some extent at the federal level; the FDA promulgated a regulation 
deeming ENDS tobacco products subject to the Family Smoking Prevention and 
Tobacco Control Act (“Tobacco Control Act”) and the agency’s regulatory 
power.6  Effective August 8, 2016, the FDA regulations impose requirements 
and restrictions on ENDS, some relatively minor and others far more significant.7  
The impact of the regulation cannot yet be measured and we fully anticipate that 
FDA will issue additional provisions and guidance related to ENDS.  
Researchers will have to wait to determine the full impact of the federal 
regulation of ENDS. In the meantime, federal law gives wide room for state and 
local jurisdictions to do more.  
  Section II of this paper provides a brief history into ENDS.  In Section III, 
we set out information about the marketing history, including data on sales, and 
in Section IV we explore the demographics of ENDS users.  Section V discusses 
the available research, summarizing what is known and noting the need for 
additional research to support policymakers and public health professionals, 
Section VI includes the history of federal regulation of tobacco, which leads into 
Section VII, which explains the new FDA regulation of ENDS via the so-called 
deeming rule. Finally, Section VIII suggests policy options for state and local 
governments interested in expanding upon the regulatory scheme established by 
FDA. 
 
winning actor openly using a vape pen during a televised award show, among others); Cf. John Tozzi, 
Celebrities Pitching E-Cigarettes Make a Nightmare for Public Health Officials, BLOOMBERG BUS.WK. 
(June 30, 2014, 4:34 PM),https://www.bloomberg.com/news/articles/2014-06-30/celebrities-pitching-e-
cigarettes-make-a-nightmare-for-public-health-officials (describing that through use of celebrities in 
marketing, e-cigarette brands are eroding the stigma of smoking that had been established in part by 
advertising bans); see, e.g., CANADAVAPES, Katherine Heigl & David Letterman Vape Electronic 
Cigarettes, YOUTUBE (Sept. 29, 2010), https://www.youtube.com/watch?v=ysGyfLwwr1s (presenting a 
clip from a network television show where two celebrities discuss e-cigarettes as a tool to quit smoking);  
 6. 21 C.F.R. §§ 1100, 1140, 1143 (2016). 
 7. See 21 C.F.R. § 1100, 1140, 1143 (2016) (stating that the rule extends the FDA’s authority to all 
statutorily defined “tobacco products,” prohibits the sale of such products to minors, and requires warning 
labels on the covered products). 
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II. HISTORY OF THE DEVICES 
Defining and describing an electronic nicotine delivery system (ENDS) is 
not an easy task as the product category has changed significantly over time and 
continues to be diverse and anything but static in design and features.8 The 
changing nature of the product is exacerbated by users modifying the product in 
various ways; there are videos available on the Internet that offer advice on how 
to modify an ENDS for a more potent or pleasant user experience.9 Similarly, 
the marketing of ENDS, such as where they are sold, how much they cost and 
how they are advertised, has been dynamic over the decade or so since the 
product has been on the market in the U.S.10  We use the term ENDS in this piece 
to capture the array of products that allow a user to inhale aerosolized liquid, 
typically containing nicotine, through an electronic device but researchers, 
manufacturers and consumers use a variety of terms to refer to ENDS.  A brief 
history of ENDS in the U.S.  helps to define the landscape on which regulation 
of the product will proceed. 
 The first version—or generation—was the closed-system electronic 
cigarette, often referred to as the cig-alike.11  Although far less popular now than 
later versions, cig-alike ENDS remain on the market today.12  These first-
generation devices are cylinder-shaped like cigarettes13 and are about the same 
size, just slightly longer and larger in diameter.14  The cig-alike body can be 
 
 8. See generally U.S. E-Cigarette Regulation: A 50 State Review, PUB. HEALTH L. CTR. (2016), 
available at http://www.publichealthlawcenter.org/sites/default/files/E-Cigarette-Legal-Landscape-50-
State-Review-November-2016.pdf (showing the various attempts of state legislatures to define and 
regulate e-cigarettes); see also History of Electronic Cigarettes, QUITDAY, https://quitday.org/electronic-
cigarettes/history-of-electronic-cigarettes/ (last visited Nov. 3, 2016) (discussing the rapid development 
of features and technologies following a surge in popularity of e-cigarettes). 
 9. See also Caleb Kekahbah, E-Cig simplified.com – E-Cigarette Cartridge Modification, 
YOUTUBE (Oct. 13, 2010), https://www.youtube.com/watch?v=6_3Gbkz4150 (demonstrating homemade 
methods of modifying e-cigarettes).See MASHABLE, How to Hack Your Own E-Cigarettes, YOUTUBE 
(Jan. 24, 2014), https://www.youtube.com/watch?v=rmxwnuTRMiw (describing various methods of e-
cigarette modification).https://www.youtube.com/watch?v=6_3Gbkz4150 (demonstrating homemade 
methods of modifying e-cigarettes). 
 10. See Arnold, supra note 3, at A246–47 (discussing market changes including the shift in sales 
from a largely online market to more “brick-and-mortar stores”). 
 11. See Lynne Dawkins, Cigalike vs. Refillable E-Cigarettes: Don’t Stub Out the Cigalikes Just 
Yet…, SAVEE-CIGS.COM (Aug. 10, 2014), https://saveecigs.wordpress.com/2014/08/10/cigalike-vs-
refillable-e-cigarettes-dont-stub-out-the-cigalikes-just-yet/ (discussing the difference between a non-
refillable, closed system e-cigarette and later refillable types of e-cigarettes). 
 12. See Tripp Mickle, E-Cigarette Sales Rapidly Lose Steam, WALL ST. J. (Nov. 17, 2015), 
http://www.wsj.com/articles/e-cig-sales-rapidly-lose-steam-1447798921 (citing a “slowdown”, a 21% 
drop in sales, of cig-alike models of e-cigarettes). 
 13. See Volt – Pro Starter Kit, SMOKELESSIMAGE, Image 4, http://smokelessimage.com/starter-
kits/voltpro.html (last visited Feb. 3, 2017); see also Dawkins, supra note 11. 
 14. See Konstantinos Farsalinos et al., Nicotine Absorption from Electronic Cigarette Use: 
Comparison Between First and New-Generation Devices, 4 SCI. REP. 1, 1 (2014) (explaining that these 
small devices are similar to regular tobacco cigarettes); Jessica M. Yingst et al., Factors Associated with 
Electronic Cigarette Users’ Device Preferences and Transition From First Generation to Advanced 
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constructed of metal or heavy plastic.15  Coloration varies from those designed 
to look like a cigarette with a brown “filter” at one end and a longer section of 
white making up the shaft to those with an all-black design.16  Although the cig-
alike does not actually burn, most of the products have a lighted end that glows 
as the user draws on the cig-alike.17  The coloration of the lighted end also varies, 
with some cig-alikes having a red/orange light, some a grey color and one 
popular product with a blue light.18  The first-generation electronic cigarette is 
comprised of three parts: an enclosed battery, a reservoir for liquid, and a heating 
element.19  The heating element uses power from the battery to change the liquid 
into an aerosol, often referred to as vapor.20 The liquid reservoir in a cig-alike is 
a prefilled cartridge.21  Some cartridges are inaccessible to the user, making the 
device disposable as the device has no purpose once the enclosed liquid is 
depleted through use.22  The batteries in these cig-alikes are not rechargeable.  
The design of other cig-alikes differs in that the cartridge can be removed and 
replaced with another closed cartridge; these cig-alikes have a rechargeable 
battery, typically using a USB port for charging.23  The voltage in the non-
rechargeable or the rechargeable battery in a cig-alike is fixed, not subject to 
consumer alteration.24  For non-disposable cig-alikes, the replacement cartridges 
 
Generation Devices, 17 NICOTINE & TOBACCO RES. 1242, 1243 (2015) (noting that the devices shaped 
like a cigarette are also classified as “cigalikes”). 
 15. Konstantinos Farsalinos et al., Are Metals Emitted from Electronic Cigarettes a Reason for 
Health Concern? A Risk–Assessment Analysis of Currently Available Literature, 12 INT’L. J. ENVTL. RES. 
& PUB. HEALTH 5215, 5216 (2015). 
 16. Rachel Grana et al., Background Paper on E-Cigarettes, WHO TOBACCO CONTROL PAPERS 1, 
13–14 (2013), http://escholarship.org/uc/item/13p2b72n. 
 17. Hayden McRobbie, Electronic Cigarettes, NCSCT (2014), at 4, 
http://www.ncsct.co.uk/usr/pub/e-cigarette_briefing.pdf.  
 18. What Is a Cigalike?, VAPERANKS, http://vaperanks.com/what-is-a-cigalike/ (last visited Feb. 20, 
2017) (explaining that some cigalikes have LED tips that light up red because are designed to look like 
real tobacco cigarettes); Lindsay Fox, Njoy Electronic Cigarette Review, ECIGARETTE REVIEWED (Apr. 8, 
2016), http://ecigarettereviewed.com/njoy-electronic-cigarette-review (reviewing an electronic cigarette 
that has a grey plastic tip with an LED that lights up white as the user inhales); How Blu Disposables 
Work, BLU, https://www.blu.com/en/US/explore/about-blu-products/disposable-e-cigarettes.html (last 
visited Feb. 20, 2017) (explaining that when the user inhales, the blue LED tip with light up). 
 19. McRobbie, supra note 17. 
 20. Tianrong Cheng, Chemical evaluation of Electronic Cigarettes, 23 TOBACCO CONTROL ii11, ii11 
(2014). 
 21. Chen et al., supra note 4, at 356.  
 22. Id.  
 23. See id. at 360 (explaining that closed system cig-alikes can be reloaded with cartridges filled by 
the manufacturers); see also 4 Ways You Can Keep Your E-Cigarette Battery Charged and Working For 
You, EVERSMOKE ELECTRONIC CIGARETTES, http://www.learn.eversmoke.com/keep-your-e-cig-battery-
charged.html (last visited Feb. 20, 2017) (explaining that batteries do not last indefinitely, and can 
typically be plugged into a laptop or other device with a USB port). 
 24. E-Cigarette Use Among Youth Adults: A Report of the Surgeon General, U.S. DEP’T OF HEALTH 
& HUM. SERV. 151 (2016), available at https://e-
cigarettes.surgeongeneral.gov/documents/2016_SGR_Full_Report_non-508.pdf; see also R.J. Reynolds 
Vapor Company, VUSE: Digital vapor cigarettes, Frequently Asked Product Related Questions, VUSE, 
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are not designed to be filled by the consumer; rather, they are supposed to be 
discarded and replaced with a new, pre-filled cartridge.25  For this reason, cig-
alikes, whether disposable or reusable, are referred to as closed-system ENDS.26  
Of course, some clever consumers found that they could save money by refilling 
the cartridges from vials of e-liquid.27  This is an adulteration of the first-
generation ENDS that foreshadowed the future generations. 
 Later generations of ENDS developed rapidly, with product changes 
reflecting increases in technology and enhanced flexibility for consumers to 
exercise more control over the device.  Although the diversity in products makes 
it difficult to define any one product variety, there are common characteristics of 
the more modern ENDS devices.28  In contrast to cig-alikes, most of the later 
generation ENDS products are open systems, meaning the product has a 
refillable reservoir or tank into which e-liquid is poured.29  Open-system ENDS 
entered the market as e-pens and similar products.30  This iteration of the ENDS 
does not look quite like a cigarette; rather, the product may look like a large pen 
or even a lipstick case.31  These are generally cylindrical and modest in size.32  
Often these are worn on lanyard around the user’s neck.33  As with any consumer 
good, however, consumer demand and technology advances changed this 
product line quickly.34  The more modern open-system ENDS boast a much 
larger e-liquid tank than early models; this is a factor of convenience as the 
 
https://www.vusevapor.com/FooterLinks/ProductFAQs (last visited Feb. 20, 2017) (“VUSE intentionally 
does not offer refillable replacement Cartridges to help ensure that our products cannot be modified and 
in turn, offer only a superior vaping experience…. The Lithium Polymer battery is housed inside the 
VUSE PowerUnit and is not accessible.”). 
 25. Id.  
 26. Chen et al., supra note 4, at 356.  
 27. smokevapure, How To Fill An E-Cigarette Cartridge With E-Liquid, YOUTUBE (Sept. 28, 2010), 
https://www.youtube.com/watch?v=cr4yPtYvzO0. 
 28. See Conference of the Parties to the WHO Framework Convention on Tobacco Control, 
Electronic Nicotine Delivery Systems and Electronic Non-Nicotine Delivery Systems (ENDS/ENNDS), ¶ 
3, FCTC/COP/7/11(Aug. 2016) (“All ENDS/ENNDS heat a solution (e-liquid) to create an aerosol which 
frequently contains flavourants, usually dissolved into Propylene Glycol or/and Glycerin.”). 
 29. See Nancy Kaufman & Margaret Mahoney, E-Cigarettes: Policy Options and Legal Issues 
Amidst Uncertainty, 43 J. L. MED. & ETHICS (SPEC. SUPP. TO VOL. 43.1) 23, 23 (2015).  
 30. See id. (noting that open-system ENDS rapidly entered the market in various designs including 
e-pens, vape pens, and other customizable devices). 
 31. See Regulating Electronic Cigarettes and Similar Devices, TOBACCO CONTROL LEGAL 
CONSORTIUM 1, 2 (2014) (describing modern ENDS which come in a “variety of shapes mimicking 
common household products, such as flash drives, pens, and lipstick.”); see also Grana et al., supra note 
16, at 14, fig.2. (depicting an example of a pen-style ENDS). 
 32. See Regulating Electronic Cigarettes and Similar Devices, supra note 31 (stating that pen-style 
ENDS are shaped like cigarettes but slightly larger).  
 33. See Matt Richtel, Where Vapor Comes Sweeping Down the Plain: E-Cigarettes Take Hold in 
Oklahoma, N.Y. TIMES (Apr. 26, 2014), https://www.nytimes.com/2014/04/27/business/e-cigarettes-
take-hold-in-oklahoma.html?_r=0 (describing an e-cigarette user who wears his e-cigarette on a lanyard 
around his neck). 
 34. See Grana et al., supra note 16, at 12 (“Product engineering has been evolving since the first e-
cigarettes were documented as arriving on the global market in 2007.”). 
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consumer is not required to refill the tank as frequently as with the first open-
system models or as often as the cartridges would be replaced in a rechargeable 
cig-alike.35  Many of these modern models allow the consumer to adjust the 
voltage of the heating element, either through changing the battery or making an 
adjustment on the device itself.36  These are often referred to as variable voltage 
devices; the voltage delivered ranges from 3.0V to 7.0V.37  Adjustments to the 
voltage impact the heating temperature which in turn impacts the quality and 
quantity of aerosol inhaled by the consumer and may impact the actual nicotine 
delivery.38  High-tech versions of this line of ENDS could have pumps connected 
to micromechanical systems, allowing consumers more control over delivery of 
the aerosol.39  Advanced ENDS may also contain “programmable logic units, 
integrated circuits, and other electronic components that are used to display 
average use cycle and safety warnings.”40  These available variations result in 
more than 466 brands of ENDS on the market as of 2014.41  Although 
technological advances coupled with anticipated product regulation may 
ultimately result in consistency, testing of existing ENDs products reveals that 
“[q]uality of product functioning and performance is highly variable and 
inconsistent.”42  
 Changes and diversity in the ENDS product lines are likewise mirrored in 
the e-liquid market.  Initially, with closed systems, e-liquid was available in the 
sealed cartridges and in a few flavors.43  As the open system product lines 
 
 35. See id. at 13, 14 fig.2 (showing Figure 2 to illustrate a large, tank-style ENDS after noting that 
larger tank systems “hold several ml of e-liquid” requiring fewer refills). 
 36. See McRobbie, supra note 17, at 6 (explaining that users can adjust the voltage of the device by 
changing the settings directly on the device or replacing the coils and wicks in the device); see also Aaron 
Bonner, Head in the Clouds: Vaping Culture Continues in Tuscaloosa, THE CRIMSON WHITE (Sept. 8, 
2016, 7:46 AM), http://www.cw.ua.edu/article/2016/09/tuscaloosa-vape-culture (“Those interested in 
modifying their kit can upgrade coils and batteries to increase voltage and intake…”). 
 37. Brown & Cheng, Electronic Cigarettes: Product Characterisation and Design Considerations, 
23 TOBACCO CONTROL (SUPPLEMENTAL ISSUE 2), at ii7 (May 2014) (giving an example of a variable 
voltage range of “3-6 V in 0.1 V increments[.]”). 
 38. See Grana et al., supra note 16, at 12 (“Battery voltage differences and unit circuitry can result in 
great variability in the products’ ability to heat and convert the nicotine solution to an aerosol and, 
consequently, may affect actual nicotine delivery and other chemicals delivered to users and emitted in 
the exhaled aerosol.”).  
 39. See Brown & Cheng, supra note 37, at ii6 (describing that micromechanical systems (MEMS) 
that employ tiny pumps to deliver “specifically programmed quantities and combinations of e-liquids” the 
user can control). 
 40. Id.  
 41. See Shu-Hong Zhu et al., Four Hundred and Sixty Brands of E-Cigarettes and Counting: 
Implications for Product Regulation, 23 TOBACCO CONTROL (SUPP. ISSUE 3) iii3, iii4–5 (July 2014), 
http://tobaccocontrol.bmj.com/content/tobaccocontrol/23/suppl_3/iii3.full.pdf (following two 
comprehensive internet searches researchers identified 466 unique e-cigarette brands as of January 2014). 
 42. Grana et al., supra note 16 at 13. 
 43. See Chen et al., supra note 4, at 356. 
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developed, the e-liquid market expanded to meet—and increase—demand.44  As 
of 2014, e-liquid was available in more than 7,700 flavors.45  In fact, with the 
rise of vape shops—specialty stores that sell ENDS products and e-liquid—there 
is an unlimited number of flavors as “mixologists” can create blends or unique 
flavors upon request and consumers can mix their own at home.46  Beyond flavor, 
the e-liquid market is also diverse with respect to nicotine content, with some e-
liquid marketed as nicotine-free and others listing nicotine concentration, 
ranging from 0 to 36 mg/mL.47 The accuracy of the nicotine level listed for e-
liquid is in serious doubt, at least in the pre-FDA regulation era.48 Research 
shows great variation in nicotine content, with some nicotine-free products 
testing as containing some amounts of nicotine and with a large %age of products 
with nicotine levels higher or lower than the listed amount.49 And little is known 
about the chemical content of e-liquid, there being no ingredient disclosure 
requirements.50  E-liquid is available in vials, bottles and “even the barrel.”51 
 The changes in ENDS and e-liquid result in—and perhaps from—changes 
in the marketing of the products.  The early first generation of closed system 
ENDS were generally quite expensive and available only in mall kiosks and 
online.52 A rechargeable, closed-system Smoking Everywhere product 
purchased by the Legal Resource Center in the mid-2000s cost $175 and was 
purchased at a suburban mall kiosk in Maryland. Quickly, however, cheaper 
versions of the product were produced and marketed alongside cigarettes and 
other tobacco products at convenience stores, gas stations, pharmacies, and more. 
 
 44. See Shu-Hong Zhu, supra note 41, at iii5 (2014) (noting that 242 new flavors were added per 
month during the study). 
 45. See id. at iii5 . 
 46. See Jean-François Etter, Levels of Saliva Cotinine in Electronic Cigarette Users, 109 ADDICTION 
825, 828 (2014) (stating that some users mixed their own ‘home-made’ e-liquid with ingredients 
purchased online); see Christian McPhate, Dark Clouds on E-Cigs’ Horizon Have Arrived, DALLAS 
OBSERVER (Oct. 31, 2016), http://www.dallasobserver.com/news/dark-clouds-on-e-cigs-horizon-have-
arrived-8853795 (explaining that many vape shops have mixed e-liquids in their backrooms using food 
additives and nicotine).  
 47. See McRobbie, supra note 17, at 8. 
 48. See Maciej L. Goniewicz et al., Nicotine Levels in Electronic Cigarette Refill Solutions: A 
Comparative Analysis of Products From the US, Korea, and Poland, 26 INT’L J. DRUG POL’Y 583, 585 
(2015) (describing a study that found that US e-liquid products showed significant differences between 
the labelled and detected nicotine). 
 49. See id. at 585. 
 50. See id. at 584 (explaining that currently the FDA has no authority to require ENDS manufacturers 
to disclose product ingredients, but predicting that the FDA will deem ENDS as tobacco products and 
bringing them within the scope of FDA regulation). 
 51. Nathan K. Cobb et al., Novel Nicotine Delivery Systems and Public Health: The Rise of the “E-
Cigarette”, 100 AM. J. PUB. HEALTH 2340, 2340 (2010) (explaining that some e-liquid is sold in bottles); 
Matt Richtel, Selling a Poison by the Barrel: Liquid Nicotine for E-Cigarettes, N.Y. TIMES (Mar. 23, 
2014), https://www.nytimes.com/2014/03/24/business/selling-a-poison-by-the-barrel-liquid-nicotine-for-
e-cigarettes.html?_r=1 (noting that e-liquid is sold in various amounts, from vials to barrels). 
 52. 2016 SURGEON GENERAL’S REPORT: E-CIGARETTE USE AMONG YOUTH AND YOUNG ADULTS, 
CDC (2016), at 14, 155, https://www.cdc.gov/tobacco/data_statistics/sgr/e-cigarettes/index.html. 
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This took the product from the unique, high-cost category into the more 
affordable, easily-accessible category.  By contrast, a disposable cherry e-hookah 
purchased by the Legal Resource Center in the early 2010s was approximately 
$5 and available in a convenience store where cigarettes and other tobacco 
products were sold. And ultimately, changes in the product sparked the 
emergence of the vape shop where consumers can buy different reusable, open-
system ENDS devices and try innumerable flavors, including special mixes 
blended in the vape shop.53  As with many consumer products, ENDS are often 
purchased online.54 
 The diverse ENDS market is somewhat bifurcated now.  Closed system 
ENDS often available in convenience stores tend to be marketed by cigarette 
manufacturers.55  For example, Blu, a very popular rechargeable closed-system 
cig-alike was first produced by Lorillard Tobacco Company and is now produced 
by Imperial Tobacco.56 Open-system ENDS devices and e-liquid, on the other 
hand, are made and distributed by any number of companies, many by small 
entrepreneurs.57  These vendors are organized by a trade association, the Smoke-
Free Alternatives Trade Association, or SFATA, which estimates that there are 
22 manufacturers of hardware, 13 assemblers of devices, more than 1200 
manufacturers and perhaps 15,000 vape shops across the country.58  SFATA 
believes that small and mid-sized business dominate the ENDS market, pushing 
back against the belief that “Big Tobacco” is leading the charge in support of 
ENDS.59 
 The dynamic evolution of ENDS makes one thing clear—there is no 
“typical” ENDS product. Given the nascent nature of the product line, the 
increasing use of ENDS and the high-tech nature of the more modern devices, it 
 
 53. See What Is A Vapeshop, BILLOWBY, https://billowby.com/blogs/learn/what-is-a-vapeshop (last 
visited Feb. 20, 2017) (reporting that at first vape shops started as an outgrowth of traditional tobacconists, 
but popularity increased to allow for expanded product lines, and vape shops appeared with different 
mixes of flavors). 
 54. See Yadira Galindo, Online E-cigarette Vendors Engage Customers Using Popular Internet 
Tools, UC SAN DIEGO NEWS CTR. (Oct. 2, 2015), 
http://ucsdnews.ucsd.edu/pressrelease/online_e_cigarette_vendors_engage_customers_using_popular_in
ternet_tools (reporting that online sales comprise 25-30% of the $2 billion annual e-cigarette market). 
 55. Mike Esterl, Big Tobacco’s E-Cig Push gets a Reality Check, MARKETWATCH (Aug. 26, 2014, 
3:59 PM), http://www.marketwatch.com/story/big-tobaccos-e-cig-push-gets-a-reality-check-2014-08-26-
154855951 (reporting that Altria group Inc. and Reynolds American Inc. quickly captured convenience 
store sales of closed-system “cigalikes”). 
 56. See Brian Solomon, Reynolds, Lorillard Dump Blu E-cigarettes In $27 Billion Merger, FORBES 
(Jul. 15, 2014, 2:53 PM), http://www.forbes.com/sites/briansolomon/2014/07/15/reynolds-lorillard-
dump-blu-e-cigarettes-in-27-billion-merger/#733d9b0bd1c6 (explaining the Lorillard sold Blu to 
Imperial in 2014, after it merged with Reynolds). 
 57. See About SFATA, SMOKE-FREE ALTERNATIVES TRADE ASS’N, http://sfata.org/about-sfata/ (last 
visited Feb. 20, 2017) (stating that the ENDS industry has provided over 70,000 jobs because of the recent 
increase in ENDS companies). 
 58. Id. 
 59. Id. 
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is impossible to surmise the future of ENDS.  This, of course, frustrates 
researchers who need time to study the impact of the product while the ticking 
of time means the studied product has become altered or obsolete before the 
study’s conclusion.  
III.  MARKET HISTORY AND SALES 
ENDS sales have increased sharply since their introduction to the U.S. 
market in 2007.60  From 2009 to 2014 annual sales increased from $39 million 
to nearly $2 billion, with average sales more than doubling each year.61  The 
growth rate slowed significantly in 2015, but sales still surpassed $3 billion.62 
Preliminary estimates for 2016 exceed $4 billion and industry projections 
indicate continued growth through at least 2023, when annual sales could surpass 
$20 billion.63 The 2014-2015 market slowdown was accompanied by a dramatic 
shift in the retail location and categories of products sold.64  Previously, 
disposable “cig-alikes” purchased in convenience stores and other mass retail 
establishments dominated the category.65  Beginning in 2014, however, open-
system personal vaporizers became the most widely purchased ENDS product.66  
These refillable devices accounted for nearly two-thirds of all ENDS sales this 
year.67  At the same time vape shops and online retailers continue to increase 
their market share at the expense of convenience stores and other mass retail 
 
 60. See Kathleen Burke, The Government Crackdown is Here: What the FDA Regulations Mean for 
E-cigarettes, MARKETWATCH (Aug. 8, 2016, 10:21 AM), http://www.marketwatch.com/story/the-
government-crackdown-is-here-what-the-fda-regulations-mean-for-e-cigarettes-2016-05-05. 
 61. See E-Cigarette Use Among Youth Adults: A Report of the Surgeon General, U.S. DEP’T OF 
HEALTH AND HUM. SERV. 152–153(2016), https://e-
cigarettes.surgeongeneral.gov/documents/2016_SGR_Full_Report_non-508.pdf. 
 62. See Susan Adams, Can E-Cigarettes Survive The War Against Vaping, FORBES (May 5, 2016, 
10:56 AM), http://www.forbes.com/sites/susanadams/2016/05/05/can-e-cigarettes-survive-the-war-
against-vaping/#39f7059269b2 (commenting that the size of the U.S. e-cigarette industry exceeded $3 
billion sales in 2015, but that sales in convenience stores and big retailers shrunk 6.2 %). 
 63. See Susan Adams, E-Cigarette Manufactures Say New Regulations Will Devastate the Industry, 
FORBES (May 5, 2016, 3:01 PM), http://www.forbes.com/sites/susanadams/2016/05/05/e-cigarette-
manufacturers-say-new-regulations-will-devastate-the-industry/#3bdcd27730bb (estimating that that the 
e-cigarette industry was worth just under $4 billion dollars last year); BIS RESEARCH, Global E-Cigarette 
& Vaporizer, Device and Aftermarket, Analysis and Forecast, 2016-2025, RES. & MARKETS (Sept. 2016), 
http://www.researchandmarkets.com/reports/3845485/global-e-cigarette-and-vaporizer-device-and 
(predicting that the e-cigarette market will grow to $47 billion by 2025). 
 64. See Mike Esterl, Big Tobacco’s E-Cig Push Gets a Reality Check, MARKETWATCH (Aug. 26, 
2014, 3:59 PM), http://www.marketwatch.com/story/big-tobaccos-e-cig-push-gets-a-reality-check-2014-
08-26-154855951 (documenting a shift in the e-cigarette market to “vape shops”). 
 65. See id. (connecting the decrease in e-cigarette convenience store sales to an increase in the vape 
shop market). 
 66. See Open System Vaporizers Officially Overtake E-Cigs, Top $1 Billion in Sales for the First-
Time Ever, MARKETWATCH (Sept. 25, 2014), http://www.marketwatch.com/story/open-system-
vaporizers-officially-overtake-e-cigs-top-1-billion-in-sales-for-the-first-time-ever-2014-09-25. 
 67. See U.S. DEP’T OF HEALTH AND HUM. SERV., supra note 61, at 150. 
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channels.68  Combined, these emerging retail channels account for 70 % of all 
ENDS sales.69  
 Total ENDS sales pale in comparison to the domestic cigarette market, 
which exceeds $100 billion annually, but the ENDS market is growing at a faster 
rate.70  In 2015, convenience store sales grew more than 7 % for ENDS versus 3 
% for cigarettes, and convenience stores represent the smallest retail market for 
ENDS.71  While cigarette sales still represent 32 % of all convenience store sales 
– the largest share of any product – sales have been declining for a quarter-
century.72 The 3 % growth last year was followed by 5 straight years of decline.73 
The timing of this growth raises the question of whether dual use of ENDS and 
cigarettes is contributing to the renewed cigarette sales growth. 
 
IV.  WHO IS USING ENDS? 
A. Adult Use 
 
 As the retail sales data indicate, ENDS use is increasing rapidly.74  The 
Centers for Disease Control and Prevention estimate that 1 in 8 adults age 18 
years or older have ever used ENDS, a threefold increase over the past two years, 
 
 68. See Esterl, supra note 64 (documenting the decrease in convenience store sales in comparison to 
vape shop and online sales). 
 69. See Martinne Geller, Special Report: When it Comes to E-Cigs, Big Tobacco is Concerned for 
your Health, REUTERS (Mar. 23, 2015, 1:52 PM), http://www.reuters.com/article/us-ecigarettes-
regulations-specialreport-idUSKBN0MJ0GN20150323. 
 70. See Tripp Mickle, E-Cigarette Sales Rapidly Los Steam, WALL ST. J. (Nov. 17, 2015, 7:15 PM), 
http://www.wsj.com/articles/e-cig-sales-rapidly-lose-steam-1447798921 (explaining that, cigarette 
volumes are down 0.5% in 2015 while ENDS have grown 114% in the past five years). 
 71. See Where The Gains Are, CSP (Apr. 15, 2016),  http://www.cspdailynews.com/category-
data/cmh/tobacco/tobacco-cigarettes-2016 (reporting the growth in unit sales for cigarettes and electronic 
smoking devices); see also Study Shows Shopping Habits of E-Cig Users, CONVENIENCE STORE 
DECISIONS (Aug. 9, 2016), http://www.cstoredecisions.com/2016/08/09/study-shows-shopping-habits-e-
cig-users/ (stating that only 8% of polled respondent bought ENDS products at a “convenience store”). 
 72. See Samantha Oller, Preliminary Overview Data From NACS State Of The Industry Summit 2016, 
CSP DAILY NEWS (May, 2016), http://www.cspdailynews.com/print/csp-magazine/article/preliminary-
overview-data-nacs-state-industry-summit-2016 (finding cigarettes accounted for $50,367 of $156,411 
total in store sales, equaling roughly 32%); see also Convenience Stores: Keep the Core; Appeal to More, 
TIMES & TRENDS,  https://www.iriworldwide.com/iri/media/iri-
clients/T_T%20May%202013%20Convenience%20Stores%2006042013.pdf (last visited Mar. 10, 2017) 
(noting that volume sales in convenience stores are down sharply and identifying as the primary factor 
that the smoking rate has declined 50% since 1965).  
 73. Salynn Boyles, Convenience Store Cigarette Sales Grew in 2015, MEDPAGE TODAY (Mar. 10, 
2017), https://www.medpagetoday.com/pulmonology/smoking/63753. 
 74. King, Brian A.et al., Trends In Awareness And Use Of Electronic Cigarettes Among US Adults, 
2010–2013,  NICOTINE TOBACCO RES. 17.2 (2015): 220 (finding awareness and use of e-cigarettes 
through enhanced marketing is rapidly increasing). 
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and 1 in 20 use ENDS regularly.75 Age and smoking status are the best predictors 
of ENDS use. Nearly 1 in 4 adults age 18-24 years have ever used ENDS, with 
use declining steadily as age increases.76 Differences across age groups were 
even more defined when examining non-smoking ENDS users.77 Nearly half of 
current cigarette smokers and more than half of former cigarette smokers have 
ever used ENDS.78 Those cigarette smokers actively attempting to quit were also 
twice as likely as other smokers to have tried ENDS.79  These data indicate older 
adults are using ENDS to quit smoking, while the majority of young adult (18-
24) ENDS users are never-smokers. 
B. Youth Use  
 
 While cigarette smoking rates among high school youth have decreased 
significantly over the past quarter-century (28% in 1991 to 11% in 2015)80, an 
estimated 5.6 million Americans currently under the age of 18 are still projected 
to die prematurely from a smoking-related disease.81 Moreover, the rate of 
decline has slowed in recent years, and one recent national survey showed a 
slight increase in cigarette smoking among high school youth between 2014 and 
2015 (9.2% to 9.3%).82  There is growing concern that the slowing decline in 
youth cigarette smoking rates is associated with the increased prevalence of 
ENDS use. Since 2011, youth ENDS use has skyrocketed, particularly among 
 
 75. CHARLOTTE A. SCHOENBORN & RENEE M. GINDI, U.S. DEP’T OF HEALTH & HUMAN SERVICES, 
NCHS DATA BRIEF NO. 217, ELECTRONIC CIGARETTE USE AMONG ADULTS: UNITED STATES, 2014 
(2015), https://www.cdc.gov/nchs/data/databriefs/db217.pdf (finding that 12.6% of adults had tried an e-
cigarette and 3.7% use them everyday); see also id. at 223 (reporting that 3.3% adults had ever used ENDS 
in 2010). 
 76. See Schoenborn & Gindi, supra note 75 (finding 21.6% of those aged 18-24 have used an ENDS 
product with use declining steadily as age increases). 
 77. See id. at 5 (reporting that 9.7% of adults aged 18-24 had tried an electronic cigarette despite 
having never tried a traditional cigarette compared to 4.9% of all adults over the age of 24). 
 78. Id. 
 79. See id. (finding 20.3% of those adults who had attempted to quit in the past year had tried an 
electronic cigarette compared to 11.8% of cigarette smokers who had not tried to quit). 
 80. Current Cigarette Smoking Among U.S. High School Students Lowest in 24 years, NAT’L YOUTH 
RISK BEHAV. SURVEYS, 1991–2015, http://www.cdc.gov/media/dpk/healthy-living/youth-risk-behavior-
survey/images/yrbs_release_graphics_smoking_2016.pdf (last visited Feb. 20, 2017). 
 81. Youth and Tobacco Use, CDC, 
http://www.cdc.gov/tobacco/data_statistics/fact_sheets/youth_data/tobacco_use/index.htm (last updated 
Apr. 14, 2016). 
 82. See Tushar Singh et al., Tobacco Use Among Middle and High School Students—United States, 
2011–2014, 64 MORBIDITY & MORTALITY WKLY. REP. 381, 385 (2015) (finding that 9.2% of high school 
students used cigarettes in 2014); see also Tushar Singh et al., Tobacco Use Among Middle and High 
School Students—United States, 2011–2015, 65 MORBIDITY & MORTALITY WKLY. REP. 361, 366 (2016) 
(finding that 9.3% of high school students used cigarettes in 2015). 
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high school students.83  From 2011 to 2015 ENDS “ever-use” increased from 
less than 1 in 20 (4.5%) to nearly 1 in 2 (44.9%) among U.S. high school students, 
and “current-use” increased from 1 in 100 (1.5%) to 1 in 4 (24.1%).84  ENDS are 
now the most commonly used tobacco product among high school students, at 
more than double the rate of cigarettes (24.1% to 10.8%).85  Moreover, youth 
ENDS users are significantly more likely to transition to cigarette smoking than 
youth non-users.86 Recent studies indicate that among “never-smokers,” youth 
ENDS users were 2 to 4 times more likely than non-users to (1) initiate cigarette 
smoking or (2) intend to smoke cigarettes in the future.87  
 In contrast to adults, most youth ENDS users have never smoked cigarettes. 
If kids are experimenting with ENDS and transitioning to cigarettes or other 
conventional tobacco products the adverse impact on population health could 
reverberate for decades. Therefore, when crafting ENDS regulations any 
potential benefits ENDS provide to adult users must be weighed against the 
 
 83. E-cigarette Use Triples Among Middle and High School Students in Just One Year, CDC 
NEWSROOM, http://www.cdc.gov/media/releases/2015/p0416-e-cigarette-use.html (last visited Feb. 20, 
2017). 
 84. Notes from the Field: Electronic Cigarette Use Among Middle and High School Students – United 
States, 2011-2012, 62 MORBIDITY & MORTALITY WKLY. REP. 729, 729 (2013) (finding that in 2011, 4.7% 
of high school students had ever used e-cigarettes and 1.5% currently used them); see also Youth Risk 
Behavior Surveillance – United States, 2015, 65 MORBIDITY & MORTALITY WKLY. REP. 1, 17 (2016) 
(finding that in 2015, 24.1% of high school students currently use electronic vapor products and 44.9% 
had ever used them). 
 85. Youth Risk Behavior Surveillance – United States, 2015, supra note 84, at 81, 91. 
 86. See Adam M. Leventhal et al., Association of Electronic Cigarette Use With Initiation of 
Combustible Tobacco Product Smoking in Early Adolescence, 314 JAMA 700, 707 (2015) (noting that 
high school students in Los Angeles who used e-cigarettes were more likely than those who never used e-
cigarettes to report initiation of combustible tobacco use). 
 87. See, e.g., Rebecca Bunnell et al., Intentions to Smoke Cigarettes Among Never-Smoking US 
Middle and High School Electronic Cigarette Users: National Youth Tobacco Survey, 2011-2013, 17 
NICOTINE TOBACCO RES. 228, 233 (2015) (reporting that youth who used electronic cigarettes were twice 
more likely to have intentions to smoke regular cigarettes than youth who never smoked electronic 
cigarettes); see also Victor M. Cardenas et al., Use of Electronic Nicotine Delivery Systems and Recent 
Initiation of Smoking Among US Youth, 61 INT’L J. PUB. HEALTH 237, 239 (2016) (finding that the use of 
electronic cigarettes was associated with recent initiation of cigarette smoking among youth); see also 
Leventhal et al., supra note 86, at 706 (noting that high school students in Los Angeles who used e-
cigarettes were more likely than those who never used e-cigarettes to report initiation of combustible 
tobacco use); see also Ji-Yeun Park et al., E-Cigarettes Use and Intention to Initiate or Quit Smoking 
Among US Youths, 106 AM. J. PUB. HEALTH 672, 675 (2016) (finding that youth who used electronic 
cigarettes were more likely to have intention to smoke cigarettes than youth who had never used electronic 
cigarettes);see also Brian A. Primack et al., Progression to Traditional Cigarette Smoking After Electronic 
Cigarette Use Among US Adolescents and Young Adults, 169 JAMA PEDIATRICS 1018, 1022 (2015) 
(identifying an association between use of electronic cigarettes and progression to traditional cigarette 
smoking among youth);see also Jessica L. Barrington-Trimis et al., E-Cigarettes and Future Cigarette 
Use, 138 PEDIATRICS 1, 6 (2016) (reporting that youth that used electronic cigarettes were six times more 
likely of initiating cigarette than youth who never used electronic cigarettes); see also Thomas A.Wills et 
al., Longitudinal Study of E-cigarette Use and Onset of Cigarette Smoking Among High School Students 
in Hawaii, TOBACCO CONTROL 5 (Jan. 25, 2016), 
http://tobaccocontrol.bmj.com/content/early/2016/01/05/tobaccocontrol-2015-052705.abstract 
(concluding that youth who uses electronic cigarettes are more likely to start smoking cigarettes). 
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burdens of increased youth use.   
 
V.  HEALTH EFFECTS 
 
 Since ENDS are relatively new to the market, the long-term health effects 
are still largely unknown.88 The absence of federal regulation and the large 
variance in ingredients and toxicant concentrations across brands likewise makes 
the toxicity of these products difficult to quantify.89 However, the limited clinical 
research conducted to this point indicates that ENDS contain carcinogens and 
toxic chemicals, albeit at lower levels than cigarettes.  In 2009, FDA analyzed 
numerous ENDS products and found they contained carcinogens, including 
nitrosamines, and “toxic chemicals such as diethylene glycol, an ingredient used 
in anti-freeze.”90 More recent clinical studies indicate dozens of e-liquid brands 
contain a litany of dangerous toxicants, including, “propylene glycol, glycerin, 
tobacco specific nitrosamines, tobacco alkaloids, carbonyls, ethylene glycol, 
diacetyl, andacetyl propionyl. . .heavy metals, and volatile organic 
compounds.”91 While some studies have found lower toxicant levels in ENDS 
aerosol than combustible tobacco, the levels frequently exceeded existing federal 
occupational safety limits on exposure to these chemicals.92 Moreover, nicotine, 
the key ingredient in most e-liquid, is highly addictive, has immediate bio-
chemical effects on the brain and body and is toxic in high doses.93 
In 2011, the National Institutes of Health (NIH) and FDA announced a joint 
study called the Population Assessment of Tobacco and Health study (PATH), 
which will analyze tobacco use behaviors, including ENDS use, among 46,000 
Americans age 12 years and older.94  In addition, NIH-FDA are jointly funding 
Tobacco Centers of Regulatory Science (TCORS) at fourteen academic research 
 
 88. 42 C.F.R. §59.203 (2017).  
 89. See E-cigarettes and Lung Health, AM. LUNG ASSOC., http://www.lung.org/stop-
smoking/smoking-facts/e-cigarettes-and-lung-health.html (last visited Feb. 20, 2017) (explaining that 
varying toxin levels in e-cigarette aerosols is one of the reasons the American Lung Association is calling 
for FDA oversight of e-cigarettes). 
 90. FDA and Public Health Experts Warn About Electronic Cigarettes, FDA (July 22, 2009), 
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm173222.htm. 
 91. 42 C.F.R. §59.203 (2017) (responding to rule comment on toxicity of e-cigarettes). 
 92. See id. at 29,032 (explaining that the FDA recognizes that aerosol exhaled by e-cigarette users 
may be less harmful that smoke from combustible tobacco); see also Konstantinos E. Farsalinos et al., 
Evaluation of Electronic Cigarette Liquids and Aerosol for the Presence of Selected Inhalation Toxins, 
17 NICOTINE & TOBACCO RES. 168, 170–71 (2015) (reporting the presence of diacetyl and acetyl 
propionyl in levels higher than National Institute for Occupational Safety and Health safety limits). 
 93. U.S. DEP’T OF HEALTH AND HUMAN SERVICES, THE HEALTH CONSEQUENCES OF SMOKING: 
NICOTINE ADDICTION: A REPORT OF THE SURGEON GENERAL 6–16 (Thomas E. Novotny & William R. 
Lynn eds., 1988), https://profiles.nlm.nih.gov/ps/access/NNBBZD.pdf. 
 94. FAQs for Researchers, POPULATION ASSESSMENT OF TOBACCO & HEALTH, 
https://pathstudyinfo.nih.gov/UI/FAQsResMobile.aspx (last visited Feb. 19, 2017). 
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centers to determine the toxicity and health effects associated with tobacco 
products, including ENDS.95 These TCORS are expected to contribute 
substantially to the evidence-base FDA will use to inform its decision-making 
on ENDS regulation and ultimately reduce tobacco-related death and disease in 
the United States.96  
A. Dual Use 
 
 Regardless of age, concomitant ENDS and cigarette use, commonly 
referred to as “dual use,” presents a growing public health concern.97  National 
surveys show that a significant number of adult and youth ENDS users are also 
using traditional cigarettes.98 In fact, more than 3 in 4 current ENDS users, adult 
and youth, are also current cigarette smokers.99 Many tobacco users believe that 
cutting down on cigarette smoking by adding another tobacco product, such as 
ENDS, reduces health risks.100  However, dual use leads to increased exposure 
to toxicants, and may be associated with an increased risk of negative health 
outcomes, including: cardiovascular disease, pancreatic and esophageal cancers, 
 
 95. See Centers Research Portfolio, NIH, https://prevention.nih.gov/tobacco-regulatory-science-
program/research-portfolio/centers (last visited Feb. 19, 2017) (informing of the collaborative effort 
between the Tobacco Regulatory Science Program and the Food and Drug Administration Center for 
Tobacco Products to conduct research in order to assist with the development of regulations); see also 
Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco Centers of Regulatory 
Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act, NIH, 
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-151.html (last visited Feb. 19, 2017) 
(explaining that the purpose of the program, in part, is to study the toxicity and health effects of tobacco 
products). 
 96. Id. 
 97. See Dual Use of Tobacco Products, CDC, 
http://www.cdc.gov/tobacco/campaign/tips/diseases/dual-tobacco-use.html (last visited Feb. 19, 2017) 
(explaining that dual use is not an effective way to safeguard health even when using less cigarettes yet 
adding other tobacco products). 
 98. See Notes from the Field: Electronic Use Among Middle and High School Students – United 
States, 2011-2012, 62 MORBIDITY & MORTALITY WKLY. REP. 729, 729 (2013) (reporting that among 
middle school and high school students current use of both e-cigarettes and conventional cigarettes 
increased); see also Schoenborn & Gindi, supra note 75, at 6 (stating that use of e-cigarettes was highest 
among current and former cigarette smokers). 
 99. See CDC, supra note 97 (reporting 76.3% youth that currently uses e-cigarettes also uses 
conventional cigarettes); see also Brian A. King et al., Trends in Awareness and Use of Electronic 
Cigarettes Among US Adults, 2010–2013, 17 NICOTINE & TOBACCO RES. 219, 224 (2015), available at 
https://academic.oup.com/ntr/article/17/2/219/2858030/Trends-in-Awareness-and-Use-of-Electronic 
(reporting 76.8% of adults that currently uses e-cigarettes also uses conventional cigarettes). 
 100. See Pratibha Nayak et al., A Qualitative Study of Vape Shop Operators’ Perceptions of Risks and 
Benefits of E-Cigarette Use and Attitude Toward Their Potential Regulation by the US Food and Drug 
Administration, Florida, Georgia, South Carolina, or North Carolina, 2015, 13 PREVENTING CHRONIC 
DISEASE 1, 3 (2016) (reporting on how sellers of ENDS products stated that customers used ENDS for 
“lifestyle factors, including health and disease conditions…”). 
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and inflammatory bowel disease.101  Moreover, light smoking (1-4 cigarettes per 
day) and non-daily smoking are still associated with a significantly higher risk 
of cancer, COPD, and heart disease.102 The only effective way to reduce the 
health risks associated with smoking is to quit.103 Dual use commonly prevents, 
rather than assists, smokers from quitting, and as such presents an obstacle to 
reducing the health risks associated with cigarette smoking.104  Future ENDS 
research must focus on whether the devices promote cessation or dual use, and 
policy initiatives should seek to prevent dual use.  
B. Cessation  
 
 Central to the debate surrounding ENDS is the potential for these devices 
to assist cigarette smokers to quit. As indicated by their increasing popularity 
among current and former smokers, a significant proportion of adult ENDS users 
report using the devices to attempt to quit.105 In fact, less than 3 % of adult non-
smokers age 25–64 years old have ever tried ENDS, compared to more than 50 
% of current and former smokers.106  It’s clear that cigarette smokers more 
commonly use ENDS, and that they primarily use the devices in an attempt to 
quit smoking, but do ENDS actually assist with smoking cessation?  We don’t 
know.   
 What we do know is that ENDS are not approved smoking cessation 
devices. FDA has approved a variety of smoking cessation products, including 
prescription medications, skin patches, lozenges, and gum.107  These approved 
products have been subject to rigorous pre-market review required in the 
 
 101. Lucy Popova & Pamela Ling, Alternative Tobacco Product Use and Smoking Cessation: A 
National Study, 103 AM. J. PUB. HEALTH 923, 923 (2013). 
 102. Rebecca E. Schane et al., Health Effects of Light and Intermittent Smoking, 121 J. AM. HEART 
ASS’N 1518, 1519–20 (2010). 
 103. See Quitting Smoking, CDC, 
http://www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/quitting/ (last updated Feb. 1, 2017) 
(“People who stop smoking greatly reduce their risk for disease and early death.”). 
 104. Dual Use of Tobacco Products, CDC, http://www.cdc.gov/tobacco/campaign/tips/diseases/dual-
tobacco-use.html (last updated Jan. 23, 2017). 
 105. See Schoenborn & Gindi, supra note 75, at 3 (indicating that e-cigarettes are much more popular 
among current and recent former smokers than long-term former smokers and never smokers); see also 
Terry F. Pechacek et al., The Potential That Electronic Nicotine Delivery Systems Can be a Disruptive 
Technology: Results From a National Survey, 18 NICOTINE & TOBACCO RES. 1989, 1994 (2016) (reporting 
that “data suggest[s] that about 2.4 million former smokers perceived that the use of ENDS may have 
helped in quitting use of regular cigarettes,”). 
 106. Schoenborn & Gindi, supra note 75, at 3. 
 107. U.S. DEPT. OF HEALTH & HUMAN SERV., INNOVATIVE PRODUCTS AND TREATMENTS TO 
ACHIEVE ABSTINENCE FROM TOBACCO USE, REDUCTIONS IN CONSUMPTION OF TOBACCO, AND 
REDUCTIONS IN THE HARM ASSOCIATED WITH CONTINUED TOBACCO USE (2013), available at 
https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/UCM348930.pdf. 
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FDCA.108 ENDS are not among these approved products and no ENDS 
manufacturer has submitted their product to FDA for evaluation or approval.109  
 We also know that the clinical studies conducted to this point indicate that 
there is significant uncertainty about the efficacy of ENDS as cessation 
devices.110  This uncertainty is largely the result of poor study methodology. 
Most existing studies are limited by a lack of randomized trials, small sample 
sizes, poor survey design, and/or variance in outcome measures.111  Moreover, 
the rapid evolution of the devices and the lack of standardization in the devices 
and e-liquid make long-term study virtually impossible; as soon as one product 
is subject to significant study, it is essentially obsolete.112 The majority of 
published, peer-reviewed studies, however, demonstrate a positive association 
between ENDS and smoking cessation.113  
 The potential for ENDS as smoking cessation devices cannot be easily 
brushed aside. An estimated 480,000 Americans die each year from cigarette 
smoking-related illness.114  Any product that has the potential to reduce the 
number of cigarette smokers must be examined.  ENDS cessation research is still 
in its early stages, and there is a need for more carefully designed and 
methodically sound studies to determine whether and how these devices may be 
helpful.   
 
 108. See id. (explaining that FDA’s premarket approval process applies to products that aim to treat 
or cure tobacco dependence). 
 109. Electronic Cigarettes, BETOBACCOFREE.GOV, http://betobaccofree.hhs.gov/about-
tobacco/Electronic-Cigarettes (last visited Feb. 19, 2017); see also Medical Device Databases; Premarket 
Approval, FDA, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm (last visited Feb. 19, 
2017) (demonstrating how as of Feb. 8, 2017 no ENDS product appears to have been submitted to the 
FDA for approval for smoking cessation). 
 110. Muhannad Malas et al., Electronic Cigarettes for Smoking Cessation: A Systematic Review, 18 
NICOTINE & TOBACCO RES. 1926, 1927 (2016).  
 111. Id. at 1927, 1931. 
 112. See Barbara Davis et al., Nicotine Concentrations in Electronic Cigarette Refill and Do-It-
Yourself Fluids, 17 NICOTINE & TOBACCO RES. 134, 139–40 (2015) (discussing the variability of nicotine 
concentrations and colors in identical refill cartridges and calling for greater standardization in the 
manufacturing process); see also Farsalinos et al., supra note 14, at 6 (arguing that Electronic Cigarette 
“technology is progressing at a fast pace and research is sometimes unable to follow this progress and 
assess the efficacy of such devices promptly.”). (explaining that Electronic Cigarette “technology is 
progressing at a fast pace and research is sometimes unable to follow this progress and assess the efficacy 
of such devices promptly.”). 
 113. Malas et al., supra note 110, at 1931–32 (finding that limited evidence seems to indicate that e-
cigarettes may be useful to help some smokers quit). 
 114. Fast Facts, CDC, http://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/ (last 
updated Dec. 20, 2016). 
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VI. REGULATORY HISTORY 
A. Tobacco Regulation Prior to 1996 
Prior to 1996, a hodgepodge of federal, state and local laws governed the 
cultivation, manufacture, advertising and promotion, distribution, and sale of 
tobacco products. The issue of tobacco and health was directly regulated by 
Congress primarily through six federal statutes: the Federal Cigarette Labeling 
and Advertising Act (1965), the Public Health Cigarette Smoking Act of 1969, 
the Alcohol and Drug Abuse Amendments of 1983, the Comprehensive Smoking 
Education Act (1984), the Comprehensive Smokeless Tobacco Health Education 
Act (1986), and the Alcohol, Drug Abuse, and Mental Health Administration 
Reorganization Act (1992).115  These statutes established advertising and 
packaging health warnings, prohibited radio and television advertisements116, 
required the Secretary of Health and Human Services (HHS) to submit a triennial 
report on “the addictive property of tobacco117,” and made receipt of federal 
substance abuse block grant dollars contingent on states enacting and enforcing 
minimum purchase age restrictions.118  Many state and local governments 
 
 115. See generally, e.g., Federal Cigarette Labeling and Advertising Act, Pub. L. No. 89–92, 79 Stat. 
282 (1965) (codified at 15 U.S.C. §§ 1331–1340) (generally providing for national standards on cigarette 
packaging); see also Public Health Cigarette Smoking act of 1969, Pub. L. No. 91–222, 84 Stat. 87 (1970) 
(requiring stronger warning language on cigarette packaging and banning cigarette advertising on 
television and radio); see also Alcohol and Drug Abuse Amendments of 1983, Pub. L. No. 98–24, 97 Stat. 
175 (1983) (establishing a new title called the Administration and Coordination of the National Institute 
of Mental Health, the national institute on Alcohol Abuse and Alcoholism, and the National Institute on 
Drug Abuse); see also Comprehensive Smoking Education Act, Pub. L. No. 98–474, 98 Stat. 2200 (1984) 
(amending the Federal Cigarette Labelling and Advertising Act to create a rotational label warning system, 
requiring cigarette packages and advertisements to rotate through four different warnings every three 
months); see also Comprehensive Smokeless Tobacco Health Education Act of 1986, Pub. L. No. 99–
252, 100 Stat. 30 (1986) (requiring health warnings on all packages and advertisements for smokeless 
tobacco); see also Alcohol, Drug, Abuse and Mental Health Administration Reorganization Act, Pub. L. 
No. 102–321 § 202, 106 Stat. 394 (1992) (substantially amending the Public Health Service Act to replace 
provisions relating to the Alcohol, Drug Abuse and Mental Health Administration, the National Institute 
on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse and the National Institute of 
Mental Health.). 
 116. 15 U.S.C. §§ 1331 (1994) (stating Congress’s policy to inform the public about any potentially 
negative health effects of smoking, using labeling and advertising regulations); 1333 (1994) (mandating 
that cigarette packages, cigarette advertisements, and outdoor billboards advertising cigarettes must have 
a Surgeon’s General Warning on them); 4402(a) (1994) (requiring that smokeless tobacco products carry 
a label warning of its potential health consequences). They also prohibit the advertisement of tobacco 
products through “any medium of electronic communication” subject to regulation by the Federal 
Communications Commission (FCC). 15 U.S.C. § 1335 (1994) (prohibiting advertisements of cigarettes 
or little cigars on electronic communications); 4402(d) (1994) (requiring manufacturers, packagers, or 
importers of smokeless tobacco products to submit a plan to the FTC specifying how they will comply 
with 4402(a)). 
 117. 42 U.S.C. § 290aa(b)(2) (1994) (requiring the Secretary of HHS to report every three years to 
Congress on certain research findings concerning “the addictive property of tobacco.”). 
 118. 42 U.S.C. § 300x-26(a)(1) (1994) (making the States’ receipt of certain federal block grants 
contingent on their making it unlawful “for any manufacturer, retailer, or distributor of tobacco products 
to sell or distribute any such product to any individual under the age of 18.”). 
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supplemented federal laws by imposing tobacco excise taxes, establishing 
licensing and zoning restrictions on the manufacture and distribution of tobacco 
products, and limiting the use of lighted tobacco products on public 
transportation and in government buildings.119  However, no federal agency was 
granted express regulatory authority over tobacco products and enforcement was 
divided among several agencies, including, the Alcohol and Tobacco Tax and 
Trade Bureau120; Bureau of Alcohol, Tobacco, Firearms, and Explosives121; 
Federal Communications Commission122; Federal Trade Commission123; and 
Substances Abuse and Mental Health Services Administration.124  
 Given its expansive drug authority, the U.S.  Food and Drug Administration 
(FDA) was perhaps best-suited to comprehensively regulate tobacco, but for 
decades disavowed jurisdiction.125  Under the Food, Drug, and Cosmetic Act 
(FDCA), FDA has authority to regulate the safety of food, drugs, and 
cosmetics.126  While originally intended to reduce abuses in the food and 
cosmetics industries, the FDCA nonetheless contains powerful provisions 
regulating “drugs,” “devices,” and “combination products.”127  These provisions 
 
 119. Julie A. Fishman et al., State Laws on Tobacco Control—United States, 1998, 48 MORBIDITY & 
MORTALITY WKLY. REP. 21 (1999), http://www.cdc.gov/mmwr/preview/mmwrhtml/ss4803a2.htm.  
 120. TTB’s Mission – What We Do, ALCOHOL AND TOBACCO TAX AND TRADE BUREAU, 
https://www.ttb.gov/consumer/responsibilities.shtml (last visited Feb. 22, 2017) (explaining that the 
agency enforces the laws regulating tobacco manufacturing and importing business and deals mainly with 
Federal excise taxes on tobacco products). 
 121. Alcohol & Tobacco, BUREAU OF ALCOHOL, TOBACCO, FIREARMS, & EXPLOSIVES, 
https://www.atf.gov/alcohol-tobacco (last visited Feb. 22, 2017) (explaining that the ATF enforces laws 
against contraband tobacco in interstate commerce). 
 122. Program Content Regulations, FED. COMM. COMM’N,  https://www.fcc.gov/media/program-
content-regulations (last visited Feb. 22, 2017) (“Advertisements for cigarettes, little cigars and smokeless 
tobacco are prohibited on any medium of electronic communication subject to the jurisdiction of the 
Federal Communications Commission.”). 
 123. Federal Trade Commission Cigarette Report for 2013, FTC (2016) 
https://www.ftc.gov/system/files/documents/reports/federal-trade-commission-cigarette-report-
2013/2013cigaretterpt.pdf (enforcing advertising laws that govern tobacco products). 
 124. About the Synar Amendment and Program, SAMHSA, https://www.samhsa.gov/synar/about (last 
visited Feb. 22, 2017) (describing SAMHSA’s role in implementing the Synar amendment, a law that 
requires states to enact and enforce laws prohibiting the sale or distribution of tobacco products to minos). 
 125. See, e.g., 1972 Hearings 239, 242 (statement of Comm’r Edwards) (“[R]egulation of cigarettes is 
to be the domain of Congress,” and “[a]ny such move by FDA would be inconsistent with the clear 
congressional intent”); see also 1983 House Hearings 74 (statement of Assistant Secretary Brandt) 
(explaining that FDA does not have the authority to regulate tobacco because it “is something that 
Congress has reserved to itself”); see also 1983 Senate Hearings 56 (statement of Assistant Secretary 
Brandt) (“Congress has assumed the responsibility of regulating the tobacco industry and regulating 
cigarettes”). 
 126. See Food, Drug, and Cosmetic Act, Pub. L. No. 717, 52 Stat. 675 (1938) (establishing the Food 
Drugs and Cosmetics act and granting authority to regulate food, drugs, devices, or cosmetics introduced 
into interstate commerce). 
 127. See Food, Drug, and Cosmetic Act section 301, 501–505 (1938) (prohibiting adulterated and 
misbranded drugs and devices and authorizing FDA to regulate them); See Safe Medical Devices Act of 
1990 section 16 (amending the FDCA to authorize regulation of “products that constitute a combination 
of a drug, device, or biological product.”). 
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authorize FDA to regulate any non-food article (“drugs”) or instrument 
(“devices”), or combination of the two (“combination products”) “intended to 
affect the structure or any function of the body.”128 Moreover, the FDCA requires 
warning labels and prohibits false and misleading therapeutic claims for all 
drugs, devices, and combination products.129 The Act also requires premarket 
approval for each, meaning a manufacturer must demonstrate to the agency that 
the product is safe before it can be made commercially available.130  
 Tobacco leaves contain nicotine, a highly addictive alkaloid stimulant, and 
a drug.131  Yet, from its inception in 1906 following passage of the Pure Food 
and Drugs Act to 1994, FDA never asserted authority to regulate tobacco 
products.132  In fact, the agency repeatedly testified before Congress that 
cigarettes and other tobacco products were outside the scope of its statutory 
authority “absent health claims establishing a therapeutic intent on behalf of the 
manufacturer or vendor.”133  The agency even went so far as to argue that if 
tobacco products were within its jurisdiction “they would have to be removed 
from the market because it would be impossible to prove they were safe for their 
intended us[e]” as required by the FDCA.134   
 
 128. 21 USC § 321(g), (h) (defining “drug” as “articles (other than food) intended to affect the 
structure or any function of the body” and “device” as “an instrument, apparatus, implement, machine, 
contrivance… intended to affect the structure or any function of the body.”); 21 USC § 353(g)(1)(A) 
(describing combination products as “products that constitute a combination of a drug, device, or 
biological product.”). 
 129. 21 U.S.C. § 352(a), (f) (2012) (deeming drugs or devices misbranded if the label is false or 
misleading or if the label does not bear adequate warnings); 21 USC § 353(g)(1) (authorizing FDA to 
regulate combination products). 
 130. See 21 U.S.C. § 360e (2012). 
 131. Nicotine Addiction and Your Health, BETOBACCOFREE.GOV, 
http://betobaccofree.hhs.gov/health-effects/nicotine-health/index.html (last visited Feb. 22, 2017) 
(explaining that tobacco leaves contain nicotine, a highly addictive drug); see also Nicotine (Code C691), 
NAT’L CANCER INST. (Jan. 30, 2016), 
https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus
&code=C691 (defining nicotine as a plant alkaloid and addictive central nervous system stimulant). 
 132. FDA v. Brown & Williamson Tobacco Corp., 529 U.S. 120, 158 (2000) (describing how the FDA 
disavowed jurisdiction over tobacco products until 1994); Significant Dates in U.S. Food and Drug Law 
History, FDA https://www.fda.gov/AboutFDA/WhatWeDo/History/Milestones/ucm128305.htm (last 
updated Dec. 19, 2014) (explaining that FDA announced its decision to regulate nicotine in 1994 in 
response to a Citizen’s petition by the Coalition on Smoking OR Health). 
 133. Brown & Williamson Tobacco Corp., 529 U.S. at 146 (citing Brief for Appellee (FDA) in Action 
on Smoking and Health v. Harris, 655 F.2d 236 (C.A.D.C.1980), in 9 Rec. in No. 97–1604 (CA4), Tab 
No. 4, pp. 14–15) (“In the 73 years since the enactment of the original Food and Drug Act, and in the 41 
years since the promulgation of the modern Food, Drug, and Cosmetic Act, the FDA has repeatedly 
informed Congress that cigarettes are beyond the scope of the statute absent health claims establishing a 
therapeutic intent on behalf of the manufacturer or vendor”). 
 134. Public Health Cigarette Amendments of 1971: Hearings before the Commerce Subcommittee on 
S. 1454, 92d Cong., 2d Sess., 239 (1972) (statement of FDA Comm’r Charles Edwards); see also Cigarette 
Labeling and Advertising: Hearings before the House Committee on Interstate and Foreign Commerce, 
88th Cong., 2d Sess., 18 (1964) (statement of Dept. of Health, Education, and Welfare (HEW) Secretary 
Anthony Celebrezze) (explaining that FDA jurisdiction over smoking products “might well completely 
outlaw at least cigarettes’’). 
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B.FDA’s About-Face on Tobacco Products  
In 1994, FDA announced it was considering regulating cigarettes and 
smokeless tobacco under its FDCA authority; marking a dramatic shift in agency 
policy after more than four decades of refusing to assert jurisdiction over tobacco 
products.135 Earlier in the year, several health advocacy organizations submitted 
citizen petitions to FDA urging the agency to regulate cigarettes containing 
nicotine as drugs under the FDCA.136 FDA Commissioner David Kessler 
responded by initiating an investigation to determine whether tobacco products 
containing nicotine were properly within the scope of the agency’s drug 
authority.137  
The central question was whether nicotine meets the statutory definition of 
“drug” under the FDCA.138  To satisfy the statutory definition, FDA had to 
determine whether: (1) nicotine “affects the structure or any function of the 
body” and (2) these effects were “intended” by the manufacturer.139  Intent could 
be established by showing that a reasonable manufacturer would foresee the 
pharmacologic effects of the product, consumers would use it for the 
pharmacologic effects, or the manufacturer designs the products to be used for 
its pharmacologic effects.140  Extensive scientific evidence conclusively 
demonstrated that nicotine affects the structure or function of the body, because 
it “causes and sustains addiction, and acts as a sedative, stimulant, and appetite 
suppressant.”141  And, through its nearly 18-month investigation – led by then 
Associate Commissioner and current Director of the Center of Tobacco Products 
(CTP), Mitch Zeller – the agency also found that the pharmacological effects of 
nicotine were intended by tobacco manufacturers based on all three statutory 
criteria: (1) nicotine’s addictive properties were widely known; (2) nearly 90% 
of users were addicted to nicotine, and 50% of youth users smoked or used 
smokeless tobacco for the “buzz” or to lose weight; and (3) industry documents 
demonstrated that tobacco manufacturers were not only aware of nicotine’s 
effect on the body, but designed their products “to enhance those effects and 
uses.”142 
 
 135. David A. Kessler et al., The Food and Drug Administration’s Regulation of Tobacco Products, 
335 NEW ENG. J. MED. 988, 988 (1996).  
 136. DAVID KESSLER, A QUESTION OF INTENT: A GREAT AMERICAN BATTLE WITH A DEADLY 
INDUSTRY 50–51, 87 (2001) (describing citizen petitions that demanded the FDA begin classifying low-
tar cigarettes as a drug). 
 137. Kessler et al., supra note 135.  
 138. Id.  
 139. Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 321(g)(1)(C) (2012).  
 140. Kessler et al., supra note 135, at 991.  
 141. Brief for Petitioner, FDA v. Brown & Williamson Tobacco Corp., 529 U.S. 120 (2000) (No. 98-
1152) (citing FDA Jurisdictional Determination 61 Fed Reg 44,630). 
 142. Mitch Zeller, 20 Years Later: Returning to FDA to Regulate Tobacco, FDA (Dec. 11, 2013), 
https://blogs.fda.gov/fdavoice/index.php/2013/12/20-years-later-returning-to-fda-to-regulate-tobacco/ 
(describing how Mitch Zeller investigated the tobacco industry from 1994-1996 and career at the Center 
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The agency’s findings conclusively established that nicotine is a drug 
within FDA regulatory authority, but the question quickly became how to most 
appropriately utilize this authority.143  At the time, 1 in 4 American adults were 
daily cigarette smokers, and millions more used smokeless tobacco.144  Given the 
sheer size of the adult population regularly using tobacco products and addicted 
to nicotine, and that 80 % of daily smokers began smoking before the age of 18, 
FDA chose to focus on preventing youth from initiating tobacco use.145  
 On August 11, 1995, the proposed rule entitled “Regulations Restricting the 
Sale and Distribution of Cigarettes and Smokeless Tobacco Products to Protect 
Children and Adolescents” was published in the Federal Register.146 The 
proposed rule focused heavily on restricting youth access to cigarettes and 
smokeless tobacco, and limiting the advertising and marketing of these products 
to children.147 The rule prohibited the sale of cigarettes and smokeless tobacco 
to individuals under the age of 18; required retailers to verify a purchaser’s age 
by photographic identification; prohibited free product samples and vending 
machines, except in adult-only facilities; limited outdoor advertising, advertising 
in publications with significant youth readership, and advertising near schools 
and playgrounds; prohibited the sale or distribution of brand-identified 
promotional nontobacco items such as hats and tee shirts; and required 
manufacturers to provide intended use information on all cigarette and smokeless 
tobacco product labels and in cigarette advertising.148  
C. Litigation Following FDCA “Drug” and “Device” Regulation 
The proposed rule generated the most responses in FDA history, with more 
than 700,000 submissions during the public comment period, representing the 
views of more than 1 million individuals and entities.149  Major tobacco 
manufacturers were among the organizations that submitted detailed comments 
 
of Tobacco Products); Brief for Petitioner at 4–5, FDA v. Brown & Williamson Tobacco Corp., 529 U.S. 
120 (200) (No. 98-1152) (citing FDA Jurisdictional Determination 61 Fed Reg 44,635–36, 44,701, 
44,849–50) (explaining the evidence that caused FDA to assert jurisdiction over tobacco). 
 143. Kessler et al., supra note 135, at 191.  
 144. Cigarette Smoking Among Adults—United States, 1995, 46 MORBIDITY & MORTALITY WKLY. 
REP. 1217 (1997), http://www.cdc.gov/mmwr/preview/mmwrhtml/00050525.htm; see also Elizabeth A. 
Mumford et al., Smokeless tobacco use 1992–2002: trends and measurement in the Current Population 
Survey-Tobacco Use Supplements, 15 TOBACCO CONTROL 166, 168 (2006). 
 145. Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco Products 
to Protect Children and Adolescents, 61 Fed. Reg. 44,396, 44,398 (Aug. 18, 1996) (to be codified at 21 
C.F.R. 801).  
 146. Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco Products 
to Protect Children and Adolescents, 60 Fed. Reg. 41,314 (Aug. 11, 1995) (elucidating the proposed rule). 
 147. See id. at 41,314 (explaining the proposed rule’s intent to restrict access to and advertising of 
cigarettes and smokeless tobacco products).  
 148. Id. 
 149. Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco to Protect 
Children and Adolescents, 61 Fed. Reg. 44,396, 44,418 (Aug. 28, 1996) (to be codified at 21 C.F.R. pt. 
801). 
2017] ELECTRONIC NICOTINE DELIVERY SYSTEMS AND THE “DEEMING RULE” 49 
to FDA.150 They also filed a joint lawsuit against FDA to enjoin the agency from 
promulgating a final rule regulating cigarettes and smokeless tobacco products 
less than one month after the rule was announced.151 Brown & Williamson, 
Lorillard, Phillip Morris, R.J.  Reynolds, and others, argued (1) FDA lacks 
jurisdictions to regulate cigarettes and smokeless tobacco, and (2) the advertising 
and marketing restrictions included in the proposed rule violate their First 
Amendment rights.152   
FDA succeeded, in part, in District Court, successfully arguing that the 
FDCA authorizes the agency to regulate tobacco products as “drugs” or 
“devices.”153 The Court found this authority is limited, however, to regulating 
the sale and distribution of tobacco products, and does not include advertising 
and marketing restrictions.154  In its decision, the District Court held that (1) 
Congress had not withheld jurisdiction to regulate tobacco products from FDA; 
(2) the agency may regulate tobacco products pursuant to its FDCA authority; 
(3) labeling restrictions and restrictions on youth access were authorized by the 
FDCA; and (4) restrictions on the advertisement and promotion of tobacco 
products were outside the scope of the FDCA.155  The decision was immediately 
appealed to the U.S.  Court of Appeals for the Fourth Circuit.156  
In Brown & Williamson Tobacco Corp.  v.  Food & Drug Administration, 
the Court of Appeals rejected FDA’s assertion of jurisdiction over tobacco 
products as customarily marketed (e.g., absent medical or therapeutic claims).157  
The Court of Appeals reversed the District Court decision, finding that tobacco 
products were neither a “drug” nor “device” within the FDCA and that Congress 
did not intend to include customarily marketed tobacco products within FDA’s 
jurisdiction.158  In support of its opinion, the Court cited FDA’s longstanding 
position that tobacco products were outside the scope of the FDCA, and that 
reading tobacco products into the statute “might well” lead to a ban.159  The 
FDCA requires that new devices be proven safe or effective prior to distribution 
or sale in the United States, and if there is a reasonable likelihood a device may 
cause injury, illness, or death, FDA must issue an immediate cease-distribution 
 
 150. Id. 
 151. Liza Goitein et al., Developments in Policy: The FDA’s Tobacco Regulations, 15 YALE L. & 
POL’Y REV. 399, 404 (1996). 
 152. Id. at 399.  
 153. Coyne Beahm, Inc. v. U.S. Food & Drug Admin., 966 F. Supp. 1374, 1380 (M.D.N.C. 1997) 
(holding that cigarettes are classified as a “drug” or “device” and therefore available for regulation). 
 154. Id. at 1398–1400. 
 155. Id. at 1377, 1379, 1388, 1400. 
 156. Brown & Williamson Tobacco Corp. v. FDA, 153 F.3d 155, 160 (4th Cir. 1998) (reversing the 
district court and holding that FDA lacked proper jurisdiction to regulate tobacco products), aff’d, 529 
U.S. 120, S. Ct. 1291 (U.S. 2000). 
 157. Id. at 161, 176. 
 158. Id. at 162. 
 159. Id. at 170, 172. 
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order.160  Since FDA concluded tobacco products were “dangerous,” “unsafe,” 
and kill more than 400,000 American each year, the Court concluded that the 
FDCA would require the agency to ban tobacco products, contrary to 
Congressional intent.161  
In assessing Congressional intent, the Court reviewed decades of proposed 
and enacted tobacco legislation.162 The main conclusions were Congress (1) 
repeatedly decided against granting FDA authority over tobacco products, and 
(2) reserved for itself regulatory authority over tobacco products.163  First, 
Congress considered more than a dozen bills between 1956 and 1989 that would 
have granted FDA authority over tobacco products.164 Each bill failed, indicating 
that Congress was aware FDA lacked jurisdiction and did not want the agency 
regulating tobacco products.  Second, Congress did enact several statutes directly 
regulating the advertising, marketing, packaging and sale of tobacco products.  
Passage of FCLAA, CSTHEA, and other legislation demonstrated clear intent 
not to delegate regulatory authority to FDA.165 With this information the Court 
reversed the holding of the District Court and concluded that FDA lacked the 
authority to regulate tobacco products under the FDCA.166  FDA sought certiorari 
in the Supreme Court.167 
D. FDA v. Brown & Williamson  
 
 The Supreme Court granted certiorari and in a 5-4 split affirmed the Court 
of Appeals’ decision that FDA lacked jurisdiction to regulate tobacco products 
as customarily marketed under the FDCA.168 Delivering the opinion for the 
Court, Justice O’Connor used much the same logic as the lower court: (1) 
tobacco products do not “fit” the FDCA because the statute requires FDA to ban 
dangerous drugs or devices, and (2) Congress did not delegate its authority to 
regulate tobacco products.169  
 The Court held that tobacco products did not “fit” the objective and scope 
 
 160. 21 U.S.C. § 360e (2012) (requiring FDA to consider the safety and effectiveness of a device when 
considering it for premarket approval); 21 U.S.C. § 360h(e)(1)(A) (2012) (authorizing FDA to recall 
devices that would cause serious adverse health consequences or death when used as intended). 
 161. Brown & Williamson Tobacco Corp., 153 F.3d at 163, 166, aff’d, FDA. v. Brown & Williamson 
Tobacco Corp., 529 U.S. 120 (2000). 
 162. Id. at 171–75. 
 163. Id. at 175–76. 
 164. Id. at 175 & n.26.  
 165. See id. at 172–75 (explaining that Congress’s enactment of FCLAA, CSTHEA, and other 
legislation “cannot be harmonized with FDA’s assertion of jurisdiction over tobacco products”). 
 166. Id. at 176. 
 167. See generally Petition for a Writ of Certiorari, FDA v. Brown & Williamson Tobacco Corp., 529 
U.S. 120 (2000) (No. 98-1152). 
 168. See Brown & Williamson Tobacco Corp., 529 U.S. at 131, 161 (O’Connor, J. majority). 
 169. See id. at 143, 160–61. 
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of the FDCA, because the FDCA was enacted to ensure that all drugs and devices 
subject to its provisions are safe for their intended use.170  This requires a 
balancing test where FDA determines whether the therapeutic benefits of a drug 
or device outweigh the potential health risks to the consumer.171 According to 
the Court, conducting such an analysis with tobacco products would be 
impossible.172  As FDA’s exhaustive investigation demonstrated, tobacco 
products are “unsafe, dangerous, and cause great pain and suffering from 
illness.”173 Thus, designating tobacco products as “devices” under the FDCA 
would require the agency to ban their distribution and sale. Since Congress 
refused to ban tobacco products, instead choosing to regulate their advertising 
and promotion, agency regulation would “plainly contradict congressional 
intent,” and therefore fall outside the scope of the FDCA.174 
Congress’ history of tobacco-specific legislation further demonstrated to 
the Court that FDA lacked jurisdiction to regulate tobacco products under the 
FDCA.175  Between 1965 and 1992 Congress enacted six separate statutes 
regulating tobacco in the interests of public health.176 None of these statutes 
granted FDA authority over tobacco products or banned their sale.177 To the 
Court majority, this legislative history “effectively ratified” FDA’s longstanding 
position that tobacco products were not subject to the FDCA and proved 
Congress did not delegate its tobacco authority to the agency.178 
In a blistering dissent, Justice Breyer (joined by Justices Stevens, Souter, 
and Ginsburg), argued that under a plain language reading of the FDCA, nicotine 
is a “drug” and tobacco products are a “device.”179 Moreover, the FDCA’s 
primary objective is to protect the public’s health; a goal that is best served by 
including tobacco products within the scope of the Act.180  Justice Breyer also 
took issue with the Court’s reading of the FDCA as requiring FDA to ban tobacco 
products.181 Instead arguing that the statute permitted the agency to choose 
alternative remedies more consistent with previous Congressional action.182  
Finally, the dissent constructs a statutory and policy argument that scientific 
 
 170. Id. at 142. 
 171. Id. at 141. 
 172. See id. (explaining that this would require an implausible inquiry into whether tobacco products 
purported benefits outweigh the risks to from their use). 
 173. Id. at 134. 
 174. Brown, 529 U.S. 161. 
 175. Id. at 156. 
 176. Id. at 143. 
 177. Id. at 144. 
 178. Id. at 156. 
 179. Id. at 164, 168–169 (Breyer, J., dissenting). 
 180. Brown, 529 U.S. 162 (Breyer, J., dissenting). 
 181. Id. at 174 (Breyer, J., dissenting) (describing the “perverse” consequence of a statute that does 
not allow FDA to weigh the consequences of a cigarette ban with the consequences of regulating 
cigarettes). 
 182. Id. at 163 (Breyer, J., dissenting). 
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advancements, such as discovering the addictive qualities of nicotine, should 
permit FDA to change agency policy related to previously unregulated products 
such as cigarettes and smokeless tobacco.183 
E. Decade-Long Legislative Battle Ensues 
 
The Supreme Court’s decision invalidated FDA’s final rule regulating 
cigarettes and smokeless tobacco, which had been promulgated in August 
1996.184 It also ensured that any future regulatory efforts would necessarily have 
to be the product of Congress.185 The issue of FDA authority over tobacco 
products lay dormant in the courts until 2008 when the agency moved to regulate 
electronic cigarettes as drug delivery devices and block their importation into the 
United States.186 
In the aftermath of the Brown & Williamson decision several bills were 
introduced authorizing FDA to regulate tobacco products.  During the 107th 
Congress (2001-2003) alone seven different bills were filed granting FDA new 
regulatory authority over tobacco products. Four bills (S. 190187, S. 2626188, S. 
2764189, and H.R. 2180190) would have created a new chapter within the FDCA 
solely regulating tobacco products, and three bills (S. 247191, H.R. 1044192, and 
H.R. 1097193) would have expanded the drug-delivery device authority to include 
tobacco products. None of the introduced bills received a vote, as legislators 
continued to work with industry representatives and public health advocates to 
craft a bill acceptable to both sides.194  
 
 183. Id. at 188–189 (Breyer, J., dissenting). 
 184. Id. at 127, 161. 
 185. Id. at 160–61. 
 186. Smoking Everywhere, Inc. v. FDA, 680 F. Supp. 2d 62, 64 (D.D.C.), aff’d sub nom. Sottera, Inc. 
v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010). 
 187. National Youth Smoking Reduction Act, S. 190, 107th Cong. (2001) (expanding the definition 
of tobacco product in the FDCA). 
 188. Youth Smoking Prevention and Public Health Protection Act, S. 2626, 107th Cong. (2002) 
(amending the FDCA to include an expanded definition of “tobacco product”). 
 189. Tobacco Livelihood and Economic Assistance for Our Farmers Act of 2002, S. 2764, 107th 
Cong. (2002) (strengthening provisions respecting adulterated and misbranded tobacco products). 
 190. National Youth Smoking Reduction Act, H.R. 2180, 107th Cong. (2001) (revises the definition 
of “tobacco product” to include any product made or derived from tobacco that is intended for human 
consumption). 
 191. Kids Deserve Freedom from Tobacco Act of 2001, S. 247, 107th Cong. (2001) (amending 
language to expand the definition of a “restricted device”). 
 192. Child Tobacco Use Prevention Act of 2001, H.R. 1044, 107th Cong. (2001) (expanding the 
Federal Food, Drug, and Cosmetic Act jurisdiction over tobacco products as drugs or devices). 
 193. FDA Tobacco Authority Amendments Act, H.R. 1097, 107th Cong. (2001) (including “a tobacco 
product” in the definition of the term “device”). 
 194. National Youth Smoking Reduction Act, S. 190, 107th Cong. (2001), available at 
https://www.congress.gov/bill/107th-congress/senate-
bill/190?q=%7B%22search%22%3A%5B%22Tobacco%22%5D%7D&resultIndex=1 (explaining that S. 
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In early 2004, Senators Ted Kennedy (D-MA) and Bill DeWine (R-OH) 
and Representatives Tom Davis (R-VA) and Henry Waxman (D-CA) introduced 
the “Family Smoking Prevention and Tobacco Control Act” (S. 2461195, H.R. 
4433196), a bipartisan bill authorizing FDA to regulate tobacco products and 
codifying the 1996 agency regulations.197  The bill was widely endorsed by both 
the tobacco industry and public health community.198  Philip Morris and the 
Campaign for Tobacco-Free Kids even proclaimed “enthusiastic” support, but 
after receiving unanimous consent in the Senate the House failed to take 
legislative action.199  Senator Kennedy and Representatives Davis and Waxman 
re-introduced the bill in 2005 and 2007, with the 2007 version even passing the 
House by a vote of 326-102.200  Strong opposition from the Bush Administration, 
the Secretary of Health and Human Services, and the FDA Commissioner, 
however, kept the upper house from voting on the bill.201 
  The 111th Congress (2009-2011) convened on January 3, 2009, and with 
the support of administration of the the newly elected President, Barack Obama, 
the Family Smoking Prevention and Tobacco Control Act (“Tobacco Control 
Act”) was reintroduced.202 The bill passed the House on April 2, 2009, the Senate 
 
190 was read twice and referred to Committee but went no further); Youth Smoking Prevention and Public 
Health Protection Act, S. 2626, 107th Cong. (2001), available at https://www.congress.gov/bill/107th-
congress/senate-bill/2626 (stating that S. 2626 was read twice and referred to Committee but went no 
further); Tobacco Livelihood and Economic Assistance for Our Farmers Act of 2002, S. 2764, 107th 
Cong. (2001), available at https://www.congress.gov/bill/107th-congress/senate-bill/2764 (explaining 
that S. 2764 was read twice and referred to Committee but went no further); National Youth Smoking 
Reduction Act, H.R. 2180, 107th Cong. (2001), available at https://www.congress.gov/bill/107th-
congress/house-bill/2180 (stating that H.R. 2180 was referred to Committee and a Subcommittee but went 
no further); KIDS Act, S. 247, 107th Cong. (2001), available at https://www.congress.gov/bill/107th-
congress/senate-bill/247 (explaining that S. 247 was read twice and referred to Committee but went no 
further); Child Tobacco Use Prevention Act of 2001, H.R. 1044, 107th Cong. (2001), available at 
https://www.congress.gov/bill/107th-congress/house-bill/1044 (stating that H.R. 1044 was referred to 
Committee but went no further); FDA Tobacco Authority Amendments Act, H.R. 1097, 107th Cong. 
(2001), available at https://www.congress.gov/bill/107th-congress/house-bill/1097 (stating that H.R. 
1097 was referred to Committee and a Subcommittee but went no further); see also C. STEPHEN REDHEAD 
& VANESSA K. KURROWS, FDA TOBACCO REGULATION: HISTORY OF THE 1996 RULE AND RELATED 
LEGISLATIVE ACTIVITY, 1998-2008 2, FN2 (Cong. Res. Serv. ed., 2009) (explaining while no bills 
received a vote in the 107th Congress, lawmakers worked for months in negotiations balancing “the 
competing interests of public health groups and the tobacco industry”). 
 195. Family Smoking Prevention and Tobacco Control Act, S. 2461, 108th Cong. (2004). 
 196. Family Smoking Prevention and Tobacco Control Act, H. R. 4433, 108th Cong. (2004). 
 197. REDHEAD & KURROWS, supra note 194, at 1–2. 
 198. Id. at 13. 
 199. Id. 
 200. Id. at 1–2. 
 201. REDHEAD & BURROWS, supra note 194, at 14 (stating that the Bush Administration, along with 
the FDA Commissioner and Secretary of HHS, were concerned that the bill would give the impression 
that the regulated tobacco products were safe, which would ultimately encourage individuals to smoke). 
 202. Family Smoking Prevention and Tobacco Control Act, H.R. 1256, 111th Cong. (2009); Statement 
of Administration Policy: H.R. 1256 – Family Smoking Prevention and Tobacco Control Act, THE 
AMERICAN PRESIDENCY PROJECT (Apr. 1, 2009), http://www.presidency.ucsb.edu/ws/?pid=85939 
(expressing the support of the Obama administration for H.R. 1256); Judy Schneider et al., The First Day 
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on June 11, 2009, and was signed by the President on June 22, 2009.203 After 
nearly 15 years, FDA was granted the authority over the tobacco products that 
the agency had asserted in its proposed 1995 rule.  
F. The Family Smoking Prevention and Tobacco Control Act 
The Tobacco Control Act gives FDA authority to regulate the manufacture, 
distribution, and marketing of tobacco products, including specific restrictions 
on the marketing of tobacco products to youth.204 The Act also requires FDA to 
reissue the 1996 regulations that were struck down in Brown & Williamson, 
including: minimum packaging requirements for cigarettes, minimum purchase 
age and ID requirements, and bans on free product samples, self-service displays, 
and tobacco-brand sponsorship of sporting and entertainment events.205 In 
addition, the Act prohibits the sale of flavored cigarettes and the use of modified 
risk terms such as “light,” “mild,” and “low tar.”206  
The Act defines “tobacco product” as “any product made or derived from 
tobacco that is intended for human consumption.”207 While this broad definition 
encompasses all tobacco products, the Act provides specific requirements and 
restrictions applicable only to cigarettes, smokeless tobacco, and roll-your-own 
tobacco.208  Congress gave FDA the power to regulate all tobacco products (e.g., 
cigars, hookah, and ENDS), but requires the agency to first promulgate a 
regulation specifically asserting that power over any tobacco products other than 
cigarettes, smokeless tobacco, and roll-your-own tobacco.209  
Most importantly, with few exceptions, the Tobacco Control Act expressly 
permits state and local governments to enact more stringent measures.210 
Previous federal tobacco legislation largely preempted state and local regulatory 
efforts.211  In Lorillard Tobacco Co. v. Reilly (2001), the Supreme Court held 
 
of the New Congress: A Guide to Proceedings on the House Floor, CONG. RES. SERV., 1 (2010) 
(explaining that the 111th congress convened on January 6, 2009). 
 203. Family Smoking Prevention and Tobacco Control Act, H.R. 1256, 111th Cong. (2009), available 
at https://www.congress.gov/bill/111th-congress/house-bill/1256. 
 204. Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, 123 Stat. 1776, 1830 
(2009) (codified at 21 U.S.C. § 301–387). 
 205. See id. at 1830. 
 206. See id. at 1799, 1812. 
 207. Id. at 1783. 
 208. See, e.g., id. at 1830−32 (prohibiting the distribution of free samples of cigarettes, smokeless 
tobacco, and other tobacco products). 
 209. See id. at 1786. 
 210. See id. at 1823 (stating that local and state governments may enact more stringent requirements 
than established by this chapter).  
 211. See Federal Cigarette Labeling and Advertising Act, Pub. L. No. 89-92, 79 Stat. 282, 283 (1965) 
(preempting state laws that would require cigarette manufacturers to print a notice on their packaging that 
indicates the health consequences of smoking); see also Public Health Cigarette Smoking Act of 1969, 
Pub. L. No. 91-222, 84 Stat. 84, 88 (1970) (preempting requirement or prohibition based on smoking and 
health imposed by the state with respect to advertising or promotion of any cigarettes packages); see also 
Comprehensive Smoking Education Act, Pub. L. No. 98-474, 98 Stat. 2200 (1984) (prohibiting state 
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that the Federal Cigarette Labeling and Advertising Act (“FCLAA”) preempted 
the Attorney General of Massachusetts from promulgating regulations banning 
cigarette advertising and sales within 1,000 feet of playgrounds and schools and 
limiting point-of-sale advertising.212  Likewise, the U.S. Court of Appeals for the 
Second Circuit held FCLAA preempted a New York City Board of Health 
regulation requiring tobacco retailers to post graphic warning signs about the 
adverse health effects of smoking.213  In contrast, the Tobacco Control Act 
preserves the authority of state and local governments to regulate the advertising, 
distribution, and sale of tobacco products: 
Nothing in this chapter, or rules promulgated under this chapter, shall be 
construed to limit the authority of. . .a State or political subdivision of a 
State. . .to enact, adopt, promulgate, and enforce any law, rule, regulation, or 
other measure with respect to tobacco products that is in addition to, or more 
stringent than, requirements established under this chapter, including a law, rule, 
regulation, or other measure relating to or prohibiting the sale, distribution, 
possession, exposure to, access to, advertising and promotion of, or use of 
tobacco products by individuals of any age, information reporting to the State, or 
measures relating to fire safety standards for tobacco products. No provision of 
this chapter shall limit or otherwise affect any State, tribal, or local taxation of 
tobacco products.214 
 The Act permits state and local governments to enact more stringent 
requirements in areas as disparate as sales and distribution, youth possession, use 
(e.g. smoke-free laws), fire safety standards, and excise taxes.215  State and local 
governments may even regulate the time, place, and manner of tobacco 
advertising and marketing within the boundaries of First Amendment 
commercial speech protections.216 Federal law still preempts, however, any 
requirement or prohibition related to product manufacturing, including 
premarket review, adulteration, misbranding, labeling, and product registration, 
as well as the content of tobacco advertisements with respect to health 
 
regulations that concern cigarette and smokeless tobacco advertisements and packaging); see also 
Comprehensive Smokeless Tobacco Health Education Act, Pub. L. No. 99-252, 100 Stat. 30, 34 (1986) 
(prohibiting federal agencies, state or local statutes or regulations requiring statements relating to the use 
of smokeless tobacco products and health).  
 212. Lorillard Tobacco Co. v. Reilly, 533 U.S. 525, 565–66, 569–71 (2001). The Court also found that 
the advertising restrictions as applied to smokeless tobacco and cigars, which were not included in 
FCLAA, violated the First Amendment. The Court did allow the ban on self-service displays to remain in 
effect, finding this to be a sales practice and not the promotion or advertising of cigarettes. Id. at 569–70 
(finding that the advertising restriction applied to smokeless tobacco and cigars and upholding ban on self-
service displays because it was a sales practice and not advertising or promotion).  
 213. 23-34 94th St. Grocery Corp. v. N.Y.C. Bd. of Health, 685 F.3d 174, 185–186 (2nd Cir. 2012).  
 214. Family Smoking Prevention and Tobacco Control Act, Pub. L. 111-31, 123 Stat. 1776, 1823 
(2009) (codified as 21 U.S.C. §387p(a)(1)). 
 215. Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, § 101(b)(3), 123 Stat. 
1823 (2009) (codified at 21 U.S.C. § 387p(a)(1) (2012)). 
 216. Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, § 203, 123 Stat. 1846 
(2009) (codified at 15 U.S.C. §1334(c) (2012)).  
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warnings.217 This preemption reflects that tobacco products manufactured in one 
state are generally available for sale across the country such that state-by-state 
product standards could cripple the industry in seeming violation of the spirit of 
the Commerce Clause.218 
G. New Kids on the Block 
 
 In 2007, ENDS manufacturers Smoking Everywhere and NJOY began 
importing inventory into the United States and marketing their products for 
“smoking pleasure.”219 Although designed to resemble traditional cigarettes, 
these cig-alike products do not burn or contain tobacco.220  In fact, NJOY’s 
promotional materials emphasized “it’s NOT a real cigarette, there is NO real 
smoke, flame, tar, or tobacco,” and promised to “deliver the nicotine hit that 
smokers crave.”221 In October 2008, FDA denied entry to a shipment of Smoking 
Everywhere products from China because they appeared to be an “unapproved 
drug-device combination product.”222 Shortly thereafter, FDA denied entry to a 
shipment of NJOY products on the same grounds.223 In response, Smoking 
Everywhere filed suit in the U.S. District Court for the District of Columbia, and 
NJOY joined as an intervenor-plaintiff.224 The ENDS manufacturers sought a 
preliminary injunction barring FDA from regulating their products under the 
drug/device provisions of the FDCA.225 They argued that Brown & Williamson 
applies equally to electronic cigarettes as to conventional cigarettes because the 
nicotine in electronic cigarettes is derived from tobacco, and that FDA lacks 
authority under the FDCA to regulate their products as customarily marketed.226 
FDA countered that the Supreme Court decision did not extend to electronic 
cigarettes, which do not contain tobacco and are not subject to the federal statutes 
 
 217. See Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, § 101(b)(3), 123 
Stat. 1823 (2009) (codified as amended in 21 U.S.C. § 378p(a)(2)(A) (2012)) (stating that federal law 
preempts state regulation relating to product manufacturing, including premarket review, adulteration, 
misbranding, labeling and product registration); see also 15 U.S.C. § 1334(b) (stating that federal law 
preempts state regulations pertaining to health-related warning labels); see generally Fact Sheet 3: 
Preemption of State and Local Authority,  TOBACCO CONTROL LEGAL CONSORTIUM 1–2 (July 2009), 
http://publichealthlawcenter.org/sites/default/files/fda-3.pdf (providing an overview of recent changes to 
preemption of tobacco regulations).  
 218. Family Smoking Prevention and Tobacco Control Act § 2(9)–(12).  
 219. Smoking Everywhere, Inc. v. U.S. Food & Drug Admin., 680 F.Supp.2d 62, 64 (D.D.C. 2010), 
aff’d sub nom. Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010). 
 220. Id. at 63–64.  
 221. Brief for Appellants at 3, Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010) 
(No. 10-5032). 
 222. See Smoking Everywhere, Inc., 680 F.Supp.2d at 64–65; see also Brief for Appellants at 4, 
Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010) (No. 10-5032). 
 223. See Smoking Everywhere, Inc., 680 F.Supp.2d at 65–66. 
 224. Id. at 64–65.  
 225. Id. at 63. 
 226. Id. at 66–67. 
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the Brown & Williamson Court relied upon in finding that Congress has not 
intended to give regulatory power over tobacco products to FDA.227 The 
injunction was granted by the District Court and FDA appealed.228 
 Similar to FDA’s attempt to regulate tobacco products in 1996, the agency 
invoked its FDCA authority to regulate drugs and drug-delivery devices when 
preventing the importation of ENDS.229 However, the issue of whether the 
agency has authority to regulate ENDS under the drug/device provisions of the 
FDCA soon became entangled with the issue of whether the Tobacco Control 
Act, signed into law on June 22, 2009, provided the agency with authority to 
regulate ENDS.230 Therefore, as the case moved to the U.S. Court of Appeals for 
the District of Columbia Circuit, the question was not only whether FDA could 
regulate electronic cigarettes, but whether Congress had authorized the agency 
to regulate electronic cigarettes under the drug-device provisions of the FDCA 
or under the Tobacco Control Act.231  
 FDA moved forward in Sottera v. Food and Drug Admin. with three main 
arguments: (1) electronic cigarettes are combination drug devices under the 
provisions of the FDCA, (2) the reasoning of Brown & Williamson does not 
apply to electronic cigarettes, and (3) the Tobacco Control Act does not restrict 
FDA’s preexisting authority under the FDCA to regulate electronic cigarettes as 
drug-delivery devices.232  First, FDA argued that unlike traditional cigarettes, the 
agency had regulated nicotine products under the FDCA, without challenge, for 
at least two decades.233  For instance, the agency regulated “Favor Smokeless 
Cigarettes,” a product virtually identical to ENDS, under its FDCA authority 
beginning in the mid-1980s.234 FDA advised Favor that the product was “a 
nicotine delivery system intended to satisfy a nicotine dependence and to affect 
the structure and one or more functions of the body” and therefore an unapproved 
new drug.235 FDA likewise had long used its drug-device authority to regulate 
nicotine hand gels, lollipops, lip balms, and water.236 All of these similar 
products were regulated as drug-devices under the FDCA, and FDA argued that 
the electronic cigarettes sold by NJOY and Smoking Everywhere were likewise 
subject to the Act’s provisions.237  
 
 227. Id. at 67–68. 
 228. Id. at 66; Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010). 
 229. Sottera, 627 F.3d at 894-95. 
 230. See id. at 892, 894.  
 231. See id. at 892. 
 232. See id. at 895. 
 233. Id. at 902 (Garland, J., concurring). 
 234. Id. 
 235. Brief for Appellant at 14–15, Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 
2010). (No. 10-5032). 
 236. Smoking Everywhere, Inc., 680 F. Supp. 2d at 79 n.13. 
 237. Brief for Appellant at 9, Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010). 
(No. 10-5032). 
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 Second, the Brown & Williamson Court gleaned from a handful of federal 
statutes that Congress had reserved tobacco authority for itself and did not intend 
for FDA to regulate cigarettes.238 In Sottera, FDA argued that Brown & 
Williamson did not apply to electronic cigarettes because, unlike conventional 
cigarettes, electronic cigarettes were not subject to any of the federal statutes 
cited in the Supreme Court case as Congress’s intent to preclude FDA oversight 
in the area of tobacco control.239 Rather, electronic cigarettes were never 
mentioned in Brown & Williamson, nor were they ever the subject of specific 
federal legislation.240 
 Third, FDA argued that the newly enacted Tobacco Control Act did not 
limit its ability to regulate electronic cigarettes or other drug-device products 
under the FDCA.241  While the Tobacco Control Act granted FDA new authority 
over any product derived from tobacco, the statute expressly excluded any drug, 
device or combination product regulated under the FDCA.242  According to FDA, 
since electronic cigarettes “fit” the drug-device statutory definition FDA was 
authorized to regulate these products under its preexisting FDCA authority.243  
NJOY opposed FDA’s action on nearly identical grounds as the cigarette 
manufacturers in Brown & Williamson.244  The company argued that (1) 
electronic cigarettes are tobacco products and (2) the FDCA does not grant FDA 
authority to regulate tobacco products absent therapeutic claims (i.e. as 
customarily marketed).245  First, the Tobacco Control Act defines “tobacco 
product” as “any product made or derived from tobacco,” which even FDA 
conceded encompasses electronic cigarettes like those sold by NJOY that contain 
nicotine derived from tobacco.246  Second, NJOY asserted that in passing the 
Tobacco Control Act Congress ratified the Brown & Williamson decision that 
FDA lacked jurisdiction over tobacco products under the FDCA.247  Given that 
Congress enacted specific legislation to regulate “any product made or derived 
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 244. Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891, 893 (D.C. Cir. 2010). 
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Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010) (No. 10-5032) (explaining that the 
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from tobacco,” the company argued that their products, which are derived from 
tobacco, could only be regulated under the Tobacco Control Act.248  
In its decision the Court of Appeals admitted that Brown & Williamson was 
not “crystal clear,” but ultimately sided with NJOY holding that electronic 
cigarettes fit into the definition of “tobacco product” under the Tobacco Control 
Act and Congress did not intend for tobacco products to be regulated as 
drug/devices absent a therapeutic claim.249 Rather than appeal the decision, FDA 
elected to regulate NJOY and other ENDS products under its tobacco control 
authority through the “deeming rule” process outlined in the Tobacco Control 
Act.250  
VII. THE “DEEMING RULE” 
 
 The Tobacco Control Act grants FDA immediate authority to regulate 
cigarettes, cigarette tobacco, smokeless tobacco, and roll-your-own tobacco, and 
contains specific prohibitions on the advertising and sale of these products.251 
The Act does not expressly regulate other tobacco products such as cigars, pipe 
tobacco, hookah, or ENDS, but FDA may promulgate regulations governing any 
product derived from tobacco.252 In order to extend agency oversight to include 
other tobacco products such as ENDS, FDA must first issue regulations 
“deeming” the product as subject to its tobacco regulatory authority.253 Once 
deemed, the agency may regulate the manufacturing, distribution, marketing, and 
sale of any tobacco product.254  
On April 25, 2014, nearly five years after the Tobacco Control Act was 
enacted, FDA published the proposed Deeming Rule in the Federal Register.255 
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The proposed rule extended agency jurisdiction to all other present and future 
products derived from tobacco, specifically including ENDS, cigars, pipe 
tobacco, nicotine gels, waterpipe/hookah tobacco, and dissolvable tobacco 
products.256  More than 135,000 comments were filed in response to the draft 
rule.257 FDA reviewed each submission, as required by statute, prior to 
submitting the final rule to the White House Office of Management and Budget 
(OMB) for approval.258 OMB approval resulted in the removal of several 
proposed regulations including the banning of flavors and premarket approval 
for ENDS.259  The final rule was published more than two years later, on May 
10, 2016, with an effective date of August 8, 2016,260 although many provisions 
governing ENDS manufacturers have later effective dates.261  
 The Deeming Rule is a foundational rule that authorizes FDA to regulate 
all products derived from tobacco.262 The rule also triggers specific requirements 
and restrictions for tobacco manufacturers and retailers.263 All newly deemed 
tobacco product manufacturers must register with the FDA and report product 
and ingredient listings; only market new products after FDA review; not make 
reduced risk claims without scientific data and FDA approval; not distribute free 
samples; and pay user fees.264 In addition, retailers may not sell tobacco products 
to individuals under 18 years of age and must check ID for anyone appearing to 
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1143), available at https://www.gpo.gov/fdsys/pkg/FR-2016-05-10/pdf/2016-10685.pdf. 
 258. See 5 U.S.C. § 553 (2012) (requiring administrative agencies to consider relevant comments); 
see also FDA Rules and Regulations, U.S. FDA, 
https://www.fda.gov/RegulatoryInformation/RulesRegulations/ (last visited Mar. 10, 2017) (explaining 
after issuing a proposed rule, it reviews the comments and if the proposed or final rule is “significant” the 
OMB must review it). 
 259. Desmond Jenson & Joelle Lester, FDA Overruled By White House On Removing Flavored Cigars 
and E-Cigarette Liquids From The Market, PUB. HEALTH L. CTR. (June 2, 2016), 
http://publichealthlawcenter.org/blogs/2016-06-02/fda-overruled-white-house-removing-flavored-
cigars-and-e-cigarette-liquids-market.  
 260. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act; 
Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for 
Tobacco Products, 81 Fed. Reg. 28,974 (May 10, 2016) (codified at 21 C.F.R. pts. 1100, 1140, 1143). 
 261. Id. at 29,003. 
 262. Id. at 28,982, 29,003. 
 263. Id. at 29,057. 
 264. Deeming Tobacco Products to Be Subject to the Federal Food, Drug, and Cosmetic Act; 
Regulations on the Sale and Distribution of Tobacco Products and Required Warning Statements for 
Tobacco Products, 79 Fed. Reg. 23,142, 23,148 (Apr. 25, 2014) (codified at 21 C.F.R. pts. 1100, 1140, 
1143). 
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be under 27 years of age; vending machine sales are prohibited except in adult-
only facilities.265 
In the Deeming Rule, FDA also clarified that all ENDS products are subject 
to the Tobacco Control Act and that most provisions regulating cigarettes, 
smokeless tobacco, and roll-your-own tobacco will extend to these products, 
including premarket approval.266 Under the Act, manufacturers of new tobacco 
products must secure FDA authorization prior to marketing their product.267 The 
agency will consider several factors in determining whether a product is new and 
therefore subject to the premarket approval process, but the most important is 
whether a “substantially equivalent” tobacco product was commercially 
available on or before February 15, 2007.268 This issue is critical for ENDS 
manufacturers because there is uncertainty as to whether any electronic devices 
containing liquid nicotine were on the U.S. market by this date.269 Without a 
substantially equivalent product, ENDS manufacturers must undergo the 
lengthy, costly, and uncertain premarket tobacco application process.270 
As discussed earlier, Favor Smokeless Cigarettes – electronic smoking 
devices that aerosolized liquid nicotine – were briefly marketed in the mid-
1980s, but these devices were non-flavored.271 Moreover, while Favor 
Smokeless Cigarettes resembled closed-system cig-alikes in size and design, 
they are likely not similar enough to the large tank open systems that dominate 
the ENDS market today for substantial equivalence. The Deeming Rule permits 
 
 265. Deeming Tobacco Products to Be Subject to the Federal Food, Drug, and Cosmetic Act; 
Regulations on the Sale and Distribution of Tobacco Products and Required Warning Statements for 
Tobacco Products, 79 Fed. Reg. 23,142, 23,160, 23,162 (Apr. 25, 2014) (codified at 21 C.F.R. pts. 1100, 
1140, 1143). 
 266. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act; 
Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for 
Tobacco Products, 81 Fed. Reg. 28,974, 28,993, 29,035 (May 10, 2016) (codified at 21 C.F.R. pts. 1100, 
1140, 1143). 
 267. Id. at 28,990, 29,035. 
 268. Id. at 28,991. 
 269. See, e.g., Daniela Saitta et al., Achieving Appropriate Regulations for Electronic Cigarettes, 5 
THERAPEUTIC ADVANCES CHRONIC DISEASE 50, 61 (2014) (stating that “[p]roducts introduced after that 
date would need to prove that they are ‘substantially equivalent’ to products that were on the market on 
or before 15 February 2007… [t]he unintended consequence of applying this provision to e-cigarettes 
would be to remove from the market products that have undergone significant improvements, freezing the 
technology at a stage of development when battery life was too short, vapour production was inconsistent 
and cartridges leaked…”). 
 270. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as 
Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and 
Distribution of Tobacco Products and Required Warning Statements for Tobacco Products, 81 Fed. Reg. 
28,974, 29,079 (May 10, 2016) (codified at 21 C.F.R. pts. 1100, 1140,1143) (providing three marketing 
pathways for new tobacco products – substantial equivalence to a valid predicate product, exemption, and 
premarket tobacco product application). 
 271. Reducing the Health Consequences of Smoking: 25 Years of Progress, U.S. DEP’T HEALTH & 
HUM. SERVS. (1989), available at https://profiles.nlm.nih.gov/ps/access/NNBBXS.pdf (describing how 
FDA determined that the Favor Smokeless Cigarette was a “new drug” under the FDCA). 
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ENDS manufacturers to continue marketing their products for up to 3 years if 
they submit substantial equivalence or premarket tobacco applications, but 
industry experts claim premarket approval would be catastrophic for the ENDS 
market.272 Several lawsuits have been filed challenging FDA’s decision to 
subject ENDS to the premarket approval process.273 In addition, Congress could 
step-in and alter the substantial equivalence date to accommodate ENDS 
manufacturers or otherwise exempt the devices from premarket approval.274 The 
regulatory landscape post-deeming remains uncertain for ENDS, but the devices 
are expected to stay on the market until FDA and the industry determine the 
appropriate pathway to regulation. 
FDA can and will adopt additional rules in the future regulating the newly 
deemed tobacco products, including ENDS.275 These rules could restrict 
ingredients or limit concentrations, restrict online sales, ban flavored products or 
self-service displays (both of which currently apply to cigarettes), or limit 
advertising and promotion.276 The Deeming Rule represents the beginning, not 
the end, of ENDS regulation. FDA may enact, and is expected to pursue, a wide 
variety of provisions not specified in the Deeming Rule in order to protect public 
health.  
A. Child Nicotine Poisoning Prevention Act 
 
 While the long-term health effects of ENDS use remain uncertain, acute 
exposure to liquid nicotine can result in immediate adverse health effects, 
particularly in young children. As little as 1 tablespoon of liquid nicotine is 
 
 272. Burke, supra note 60 (stating that “if the FDA’s current approach is implemented, producers 
would be required to remove every single product from the market and submit expensive and burdensome 
applications for the chance to allow their products to stay on the market”). 
 273. Lydia Wheeler, Lawsuits Mount Against FDA Regs on E-cigarettes, THE HILL (Jul. 10, 2016), 
http://thehill.com/regulation/court-battles/287056-lawsuits-mount-against-fda-regs-on-e-cigarettes (“five 
lawsuits have been filed against the agency over the rules finalized… which require any product that hit 
store shelves after February 2007 to go through a costly approval process). 
 274. Vaporizers, E-Cigarettes, and other Electronic Nicotine Delivery Systems (ENDS), FDA, 
http://www.fda.gov/TobaccoProducts/Labeling/ProductsIngredientsComponents/ucm456610.htm (last 
visited Mar. 10, 2017). 
 275. See Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as 
Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and 
Distribution of Tobacco Products and Required Warning Statements for Tobacco Products, 81 Fed. Reg. 
28,974, 28,975 (May 10, 2016) (codified at 21 C.F.R. pts. 1100, 1140,1143) (explaining that the deeming 
rule allows them to regulate newly deemed tobacco products appropriately for the protection of public 
health and they plan to do so). 
 276. See Vaporizers, E-Cigarettes, and other Electronic Nicotine Delivery Systems (ENDS), supra 
note 274 (explaining that FDA now regulates the “manufacture, import, packaging, labeling, advertising, 
promotion, sale, and distribution of ENDS”); see also Commonly Asked Questions: About the Center for 
Tobacco Products, FDA, 
http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/AbouttheCenterfo
rTobaccoProducts/ucm378205.htm (last visited Mar. 10, 2017) (explaining that the existing framework 
for traditional cigarettes is being extended to newly deemed tobacco products).  
2017] ELECTRONIC NICOTINE DELIVERY SYSTEMS AND THE “DEEMING RULE” 63 
“capable of killing four small children.”277 Even smaller levels of exposure to 
liquid nicotine, whether absorbed through the skin or eyes, or ingested, can lead 
to nausea, cardiac arrest, seizure, or coma.278 In 2014, poison control centers 
received more than 4,000 liquid nicotine exposure calls, and over half were for 
young children.279  
 To address the rising number of accidental liquid nicotine poisonings, 
Congress enacted the Nicotine Poisoning Prevention Act in January 2015.280  The 
Act requires any liquid nicotine container sold in the United States to meet the 
“special packaging” requirements for hazardous household products.281  
Beginning July 26, 2016, all liquid nicotine containers must be significantly 
difficult for children under 5 years of age to open, which is the standard for all 
hazardous household substances.282  This means 80 % of the children tested are 
unable to open the packaging within 10 minutes. The Act also grants the 
Consumer Products Safety Commission (CPSC) the power to enforce the new 
provisions.283 Finally, the Act does not limit FDA’s authority over ENDS or 
liquid nicotine.284 Rather, FDA is permitted to otherwise regulate liquid nicotine, 
including adopting more stringent packaging standards.285  
VIII. STATE AND LOCAL POLICY RECOMMENDATIONS 
Prior to the Tobacco Control Act, tobacco products were primarily 
regulated at the state and local level.286 With its passage, FDA stepped to the fore 
of tobacco regulation, establishing and administering a comprehensive federal 
tobacco control program.287 The agency now regulates the manufacture, 
marketing, labeling, distribution, and sale of tobacco products; develops mass 
media campaigns to educate the public about the dangers of tobacco products; 
 
 277. S. REP. NO. 114-12, at 1–2 (2015). 
 278. Neal L. Benowitz et al., Prolonged Absorption with Development of Tolerance to Toxic Effects 
After Cutaneous Exposure to Nicotine, 42 CLINICAL PHARMACOLOGY & THERAPEUTICS 119, 119–20 
(1987). 
 279. E-Cigarettes and Liquid Nicotine, AM. ASS’N POISON CONTROL CTRS., 
http://www.aapcc.org/alerts/e-cigarettes/ (last visited Mar. 10, 2017). 
 280. Child Nicotine Poison Prevention Act of 2015, Pub. L. No. 114-116, 130 Stat. 3 (codified at 15 
U.S.C. § 1471 (2016)).  
 281. Id.  
 282. Liquid Nicotine Packaging Surveillance Revised Guidance, U.S. CONSUMER SAFETY COMM. 
(July 22, 2016), https://www.icphso.org/files/cpsc/cpsc-guidance-liquid-nicotine.pdf (informing the 
industry that all liquid nicotine must be sold in “special packaging” as of July 26, 2016); 16 C.F.R. § 
1700.1(a) (2016) (defining “special packaging” as packaging that is “significantly difficult for children 
under 5… to open”). 
 283. Child Nicotine Poisoning Prevention Act of 2015, Pub. L. No. 114-116, 130 Stat. 3 (2016) 
(codified at 15 U.S.C. §1471). 
 284. Id. 
 285. Id. 
 286. Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, 123 Stat. 1776 (2009). 
 287. Id. (adding additional regulations and legislation to tobacco and other drugs in order to assist in 
preventing adolescent drug use due to recent failures to prevent wide-spread drug use). 
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and funds and directs scientific research to better understand the harms 
associated with tobacco use and how to reduce them.288  Through the Deeming 
Rule FDA also expanded its jurisdiction to include any product derived from 
tobacco, including ENDS.289  But, the Tobacco Control Act and the Deeming 
Rule leave significant gaps in regulation.290  Gaps that state and local 
governments are expressly authorized by the Tobacco Control Act to fill.291  
In 2014, the Surgeon General released The Health Consequences of 
Smoking – 50 Years of Progress, a 900-page report highlighting the progress 
made to reduce tobacco use in the United States and looking ahead to the 
immense burdens still presented by smoking.292 Chapter 14 of the report 
identifies the most effective tobacco control measures for decreasing youth 
tobacco use: (1) taxation/price increases, (2) restricting indoor use, (3) restricting 
youth access, and (4) bans and restrictions on advertising and promotion.293  
These measures have been largely credited with reducing youth cigarette 
smoking rates from 28 % in 1991 to 9.3 % in 2015.294  Yet, federal laws mostly 
do not extend these effective measures to ENDS.295  
Cigarettes are subject to a $1.01 per pack federal excise tax, while ENDS 
and e-liquid are not subject to any federal taxation.296 The Deeming Rule extends 
youth sales and ID check provisions to ENDS, but not the bans on self-service 
displays and flavored products.297 Cigarette advertising is heavily regulated, with 
bans on television and radio ads, event sponsorship, promotional items, and 
 
 288. Mitchell Zeller, Progress and Challenges: The State of Tobacco Use and Regulation in the U.S., 
FOOD & DRUG ADMIN. (May 15, 2014), https://www.fda.gov/NewsEvents/Testimony/ucm397399.htm. 
 289. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as 
Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and 
Distribution of Tobacco Products and Required Warning Statements for Tobacco Products, 81 Fed. Reg. 
28,974 (May 10, 2016) (to be codified at 21 C.F.R. pts. 1100, 1140, 1143). 
 290. State and Local Tobacco Regulation in a Post-Deeming World, TOBACCO CONTROL LEGAL 
CONSORTIUM, http://publichealthlawcenter.org/sites/default/files/resources/tclc-fda-deemingreg-state-
and-local-regulation-2016.pdf (last updated May, 2016) (noting there are gaps for smokeless tobacco, 
cigars, e-cigarettes and others in areas like prohibition on self-service displays, minimum package size 
requirements, prohibition on characterizing flavors and required notice of advertising in a non-traditional 
medium). 
 291. Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, 123 Stat. 1776, 1823 
(2009). 
 292. OFFICE OF THE SURGEON GENERAL, U.S. DEP’T OF HEALTH AND HUMAN SERVICES, THE 
HEALTH CONSEQUENCES OF SMOKING – 50 YEARS OF PROGRESS (2014). 
 293. Id. at 788. 
 294. Cigarette Smoking Among U.S. High School Students at an All-Time low, but E-Cigarette Use a 
Concern, CDC (2016), https://www.cdc.gov/media/releases/2016/p0609-yrbs.html. 
 295. Michael Freiburg, Options for State and Local Governments to Regulate Non-Cigarette Tobacco 
Products, 21 ANNALS HEALTH L. 407 (Dec. 2012). 
 296. Federal Excise Tax Increase and Related Provisions, ALCOHOL & TOBACCO TAX & TRADE 
BUREAU, https://www.ttb.gov/main_pages/schip-summary.shtml (last updated Sept. 4, 2012) (listing 
tobacco products subject to federal taxes, a list that does not include ENDS or e-liquid products). 
 297. State and Local Tobacco Regulation in a Post-Deeming World, supra note 290. 
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magazines with youth readership.298  In contrast, ENDS may be marketed on any 
medium, including TV, radio, magazines, billboards, and the internet.299  
As discussed, the Tobacco Control Act preserves the authority of state and 
local governments to further regulate ENDS.300 The following are evidence-
based policy interventions that communities across the country have 
implemented to reduce youth tobacco use. These policies can and should be 
extended to ENDS to tackle rising youth use, and a growing number of 
jurisdictions have applied many of these provisions to ENDS.  In some instances, 
these are laws passed to apply specifically to ENDS; in others, jurisdictions are 
choosing to incorporate ENDS into laws that already regulate tobacco products 
and new provisions regulating tobacco products. The dynamic of including 
ENDS in laws regulating tobacco products should expand now that FDA has 
deemed ENDS to be tobacco products.301  
A. Retail Licensing 
Retail tobacco licensing laws require businesses to secure a license prior to 
selling tobacco products.302 The license enables the state or local government to 
identify tobacco retailers and conduct enforcement checks to ensure compliance 
with tobacco regulations.303 Jurisdictions may also use retail licensing to restrict 
the density and location of tobacco retailers or suspend or revoke the ability to 
sell tobacco products for failure to adhere to tobacco regulations.304 
At least 40 states and the District of Columbia require tobacco retailers to 
secure a retail tobacco license.305 In contrast, only 14 states and the District of 
 
 298. Public Health Cigarette Smoking Act of 1969, Pub. L. No. 91-222 § 6, 84 Stat. 87, 89 (1970) 
(making it illegal to advertise cigarettes on any medium of electronic communication subject to the 
jurisdiction of the FCC); 21 C.F.R. §§ 1140.32, 1140.34 (2016) (prohibiting cigarette advertisements in 
youth magazines, promotional material, and sponsorship of events). 
 299. Electronic Nicotine Delivery System: Key Facts, CDC OFF. ON SMOKING & HEALTH, 
https://www.cdc.gov/tobacco/stateandcommunity/pdfs/ends-key-facts-oct-2016.pdf. 
 300. Family Smoking Prevention and Tobacco Control Act, Pub. L. 111-31, 123 Stat. 1776, 1823 
(2009) (codified as 21 U.S.C. §387p(a)(1)). 
 301. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, 81 Fed. 
Reg. 28974, 29028 (May 10, 2016) (to be codified at 21 C.F.R. pts. 1100, 1140, and 1143). Although FDA 
now considers ENDS to be tobacco products by definition, most state and local laws define tobacco 
product differently such that the law needs to be amended to include ENDS in any tobacco product 
regulation. See Lauren K. Lempert et al., The importance of product definitions in US e-cigarette laws 
and regulations, TOBACCO CONTROL, (2014), 
https://tobacco.ucsf.edu/sites/tobacco.ucsf.edu/files/u795/glantz_tobcontrol_ecig_laws%20and%20regs.
2014.pdf (explaining that most state laws define “tobacco product” differently than FDA).  
 302. Ian McLaughlin, License to Kill?: Tobacco Retailer Licensing as an Effective Enforcement Tool, 
TOBACCO CONTROL L. CONSORTIUM, 1,1 (Apr. 2010), 
http://publichealthlawcenter.org/sites/default/files/resources/tclc-syn-retailer-2010.pdf. 
 303. Id. at 2. 
 304. Id. at 8.  
 305. See Nationwide Tobacco Retailer License Fees, LEGAL RES. CTR. FOR PUB. HEALTH POL’Y, 
https://www.law.umaryland.edu/programs/publichealth/documents/Nationwide_Tobacco_Retailer_Lice
nse_Fees_One_Pager.pdf (last updated May, 2016) (ranking annual tobacco retailer license fees by state). 
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Columbia have incorporated ENDS into existing retail tobacco licensing 
schemes or enacted ENDS-specific licensing provisions.306 This means that in 
36 states, the location, prevalence, and density of ENDS retailers is unknown.307 
The rise of vape shops, which generally do not sell traditional tobacco products 
and therefore are not required to secure a special trader’s license, further 
complicates this issue. Active tobacco compliance check programs are the most 
effective measure at reducing youth tobacco access and licensing fees can be 
used to support enforcement efforts.308 Without being able to identify the stores 
selling ENDS, enforcement entities are incapable of preventing youth access to 
tobacco products.  
B. Advertising and Promotion Bans  
 
 In 2014, more than 18 million middle and high school students (7 in 10) 
were exposed to ENDS advertising in retail stores, the internet, magazines and 
newspapers, and television and movies.309 ENDS industry advertising 
expenditures increased from $6 million to $115 million between 2011 and 2014, 
and over this same time youth use more than quadrupled.310  The Tobacco 
Control Act authorizes state and local governments to regulate the time, place 
and manner of ENDS advertising.311 This means that communities may limit the 
location, number, and size of ENDS ads at retail outlets, including prohibiting 
ads near cash registers or at youth eye level.  Interested communities should be 
aware that attempts to regulate ENDS advertising must comply with the First 
Amendment, state constitutional law, and the Federal Cigarette Labeling and 
 
 306. See U.S. E-Cigarette Regulation: A 50-State Review, TOBACCO CONTROL L. CONSORTIUM,  4, 8, 
18, 26–27, 30–32, 34–35, 43, 45, 56, 67, 74–77, 81 (June 15, 2016), 
http://publichealthlawcenter.org/sites/default/files/tclc-50state-The-Legal-Landscape-for-Electronic-
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Maine, Missouri, Montana, North Carolina, Rhode Island, Utah, Washington and Vermont). 
 307. Id. 
 308. See Lindsay F. Stead & Tim Lancaster, A Systematic Review of Interventions for Preventing 
Tobacco Sales to Minors 9 TOBACCO CONTROL 169, 175 (2000), 
http://tobaccocontrol.bmj.com/content/tobaccocontrol/9/2/169.full.pdf (explaining that the successful 
interventions used a variety of active compliance check strategies including personal visits and mobilizing 
community support); see also McLaughlin, supra note 302, at 2 (noting the benefits of self-funding 
licensing fee programs). 
 309. E-Cigarette Ads and Youth, CDC (Jan. 5, 2016), http://www.cdc.gov/vitalsigns/ecigarette-ads/. 
 310. Id. 
 311. Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, 123 Stat. 1776, 1823 
(2009) (codified at 21 U.S.C. § 387p (2012)). 
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Advertising Act.312 Recent attempts to restrict retail advertising have been met 
with legal challenges from the tobacco industry, with mixed results.313  
C. Sales Restrictions 
Sales restrictions are among the most effective strategies to reduce youth 
tobacco use. These restrictions include raising the minimum sales age, restricting 
the sale of flavored products, and restricting self-service displays.314 Following 
the Deeming Rule federal law sets the minimum age to purchase any tobacco 
product at 18 years, but state or local governments may raise the age of access.315 
Four states (Alabama, Arkansas, New Jersey, and Utah) set the minimum sales 
age at 19, while two others (California and Hawaii) have recently raised it to 
21.316 More than 100 localities have joined California and Hawaii in raising the 
minimum sales age to 21 including Boston, Chicago, Cleveland, and New 
York.317  While primarily targeted at cigarettes, minimum age sales restrictions 
generally incorporate ENDS into the law.318 Preliminary studies indicate that 
raising the minimum sales age significantly reduces tobacco use by youth age 
12-17 years old.319  
 
 312. Restricting Tobacco Advertising, TOBACCO CONTROL L. CONSORTIUM, 3–4, 
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Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and 
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The Tobacco Control Act bans the sale of flavored cigarettes and the use of 
self-service displays for cigarettes and smokeless tobacco (e.g., customer may 
directly handle the product).320 Despite their effectiveness in reducing youth 
smoking rates, the Deeming Rule did not extend these provisions to ENDS.321  
As mentioned earlier, FDA originally included a flavor ban in its draft final rule, 
but the White House Office of Management and Budget removed this 
provision.322 Flavored ENDS products are extremely popular among youth and 
likely play a role in ENDS initiation.323 More than 85 % of youth ENDS users 
prefer flavored products and more than 80 % use ENDS because “they come in 
flavors I like.”324  A handful of municipalities, including Chicago, Illinois, 
Minneapolis, Minnesota, New York, New York, and Providence, Rhode Island 
have enacted sales restrictions on flavored tobacco products.325 The tobacco 
industry challenged the Chicago, New York, and Providence ordinances, arguing 
that the flavor restrictions were preempted by the Tobacco Control Act and 
unconstitutional.326 Each was held to be a legal and valid use of local authority.327  
 
 320. Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, 123 Stat. 1776 
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flavored tobacco except menthol, mint, or wintergreen products).  
 326. See 76 Enterprises, Inc. v. City of Chicago, No. 14-CV-08306 (N.D. Ill. Nov. 4, 2014) (order 
denying tobacco company’s request for a temporary restraining order against Chicago flavored-tobacco 
ordinance); U.S. Smokeless Tobacco Mfg. Co. v. City of N.Y., 703 F. Supp. 2d 239 (S.D.N.Y. Mar. 23, 
2010) (denying injunction sought by tobacco company against ordinance banning sale of flavored tobacco 
products); Nat’l Ass’n of Tobacco Outlets, Inc. v. City of Providence, 731 F. 3d 71 (1st Cir. Sept. 30, 2013) 
(affirming district court’s judgment in favor of the city against tobacco manufacturer’s challenge to 
flavored-tobacco ban).   
 327. See e.g., Chicago - 76 Enterprises Inc., 1:14-cv-08306 at 4 (noting that many jurisdiction’s 
tobacco control ordinances were considered constitutional and within the valid use of local authority); see 
also U.S. Smokeless Tobacco Mfg. Co., LLC, 703 F.Supp.2d. at 1(noting that many jurisdiction’s tobacco 
control ordinances were considered constitutional and within the valid use of local authority); see also 
National Ass’n of Tobacco Outlets, Inc., 731 F.3d at 89 (noting that many jurisdiction’s tobacco control 
ordinances were considered constitutional and within the valid use of local authority).  
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Although the tobacco industry may always push the preemption argument, the 
statutory language and case law should give confidence to communities 
considering flavor restrictions. Other hurdles may exist, such as the process of 
enforcing flavored restrictions, so policymakers should be clear and 
comprehensive when having such legislation drafted.328   
D. Indoor Air Restrictions  
Laws restricting indoor smoking are effective at reducing exposure to 
secondhand smoke and cigarette smoking rates, particularly among youth.329  As 
of October 1, 2016, 25 states and the District of Columbia have enacted 
comprehensive laws restricting smoking in indoor workplaces, including bars 
and restaurants.330  In addition, tens of thousands of counties and municipalities 
have implemented clean indoor air laws.331  These policies vary by location, but 
can also include schools, hospitals, college campuses, and other public places.332  
 Most clean indoor air laws restrict the use of a lighted tobacco product in 
the indoor space; since ENDS do not burn tobacco most clean indoor air laws 
and policies do not restrict their use.333  While the long-term effects of 
secondhand exposure remain uncertain, several public policy arguments support 
expanding clean indoor air laws to include ENDS.  First, permitting ENDS use 
may make it more difficult to enforce existing clean indoor air laws.334  Many 
ENDS brands resemble cigarettes and the devices were specifically designed to 
mimic the act of smoking.335  Second, the precautionary principle dictates that in 
 
 328. See, e.g., Regulation Flavored Tobacco Product, PUB. HEALTH L. CTR. 1, 4 (Sept. 2017) 
http://www.publichealthlawcenter.org/sites/default/files/resources/Regulating-Flavored-Tobacco-
Products-2017.pdf, (describing the elements of well-crafted laws that communities can easily enforce 
them). 
 329. See, e.g., U.S. DEP’T OF HEALTH AND HUMAN SERVICES, supra note 292, at 795 (noting how 
statutes that restricted indoor smoking led to a reeducation in smoking rates, secondhand smoking 
exposure, and smoking use in youth populations). 
 330. See e.g., U.S. 100% Smokefree Laws in Non-Hospitality Workplaces AND Restaurants AND 
Bars, AMERICANS FOR NON-SMOKERS’ RIGHTS, http://www.no-smoke.org/pdf/WRBLawsMap.pdf (map 
and list downloadable as pdf). 
 331. Id.  
 332. Id. (noting that each municipality has unique laws prohibiting indoor use of ENDS with some 
banning all indoor use while other municipalities ban them in select locations like schools, college 
campuses, and hospitals).  
 333. See, e.g., Dustin Heap, No Smoking Laws For All Fifty States, SIGNS.COM (May 20, 2014), 
https://www.signs.com/blog/no-smoking-laws-for-all-fifty-states/ (noting how most state statues only 
cover traditional tobacco products).  
 334. See, e.g., Kristy Marynak et al., State Laws Prohibiting Sales to Minors and Indoor Use of 
Electronic Nicotine Delivery Systems – United States, November 2014, 63 MORBIDITY & MORTALITY 
WKLY. REP. 1145 (Dec. 12, 2014), https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6349a1.htm 
(explaining how ENDS use could raise hardships in enforcement of smoke-free policies).  
 335. Chen et al., supra note 4 at 356 (describing closed system e-cigarettes as designed to look like 
regular cigarettes); see also E-cigarettes: What are Electronic Cigarettes?, QUIT.ORG, 
http://www.quit.org.au/resource-centre/policy-advocacy/policy/e-cigarettes1 (last visited Mar. 10, 2017) 
(stating that ENDS are designed to simulate the act of smoking). 
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cases of serious threats to health (or the environment) scientific uncertainty 
should not be used to delay preventative measures.336  The devastating toll 
tobacco has taken on the United States and the globe is undisputed – more than 
100 million people were killed by tobacco during the 20th century.337  Until 
researchers can determine whether and to what extent ENDS aerosol is harmful, 
the use of these devices should be restricted in indoor areas open to the public.  
Third, youth are particularly susceptible to tobacco marketing and studies 
indicate they perceive ENDS as less harmful (or in some cases safe) compared 
to cigarettes.338  Permitting indoor ENDS use could reinforce these beliefs and 
promote youth ENDS use.  
 State and localities have begun to incorporate ENDS into existing clean 
indoor air laws.339 At least 10 states have prohibited ENDS use in indoor 
workplaces, including bars and restaurants, and more than a dozen others have 
restricted ENDS use in schools, government facilities, public transportation and 
similar public venues.340  In addition, more than 500 hundred counties and 
municipalities across the country have laws regulating the indoor use of 
ENDS.341  None of these acts has been the subject of reported legal challenge; 
policymakers should be mindful when drafting such a provision to be clear about 
the basis for the inclusion of ENDS, relying on the current state of the research 
and noting the precautionary principle.342   
 
 336. WHO, THE PRECAUTIONARY PRINCIPLE: PROTECTING PUBLIC HEALTH, THE ENVIRONMENT AND 
THE FUTURE OF OUR CHILDREN 7 (Marco Martuzzi & Joel A. Tickner eds., 2004), available at 
http://www.euro.who.int/__data/assets/pdf_file/0003/91173/E83079.pdf. 
 337. See, e.g., Global Cancer Prevention and Early Detection, AM. CANCER SOC’Y, 
http://www.cancer.org/aboutus/globalhealth/tobacco-control (last visiting Mar. 10, 2017) (explaining how 
100 million people were killed by tobacco in the 20th century and as many as 1 billion are expected to die 
in the 21st century).   
 338. See U.S. DEP’T HEALTH & HUMAN SERVICES, PREVENTING TOBACCO USE AMONG YOUTH AND 
YOUNG ADULTS: REPORT OF THE SURGEON GENERAL 512 (2012) (noting studies that have found that 
advertisements often increase adolescents’ desire to smoke); see B.K. Ambrose et al., Perceptions of the 
Relative Harm of Cigarettes and E-Cigarettes Among U.S. Youth, 47 AM. J. PREVENTIVE MED., S53-S60, 
1, 7 (2014) (indicating that adolescents who perceive a continuum of cigarette related harm consistently 
perceived e-cigarettes as less harmful than conventional cigarettes). 
 339. States and Municipalities with Laws Regulating Use of Electronic Cigarettes, AM. 
NONSMOKERS’ RIGHTS FOUND. (Jan. 2, 2017), http://www.no-smoke.org/pdf/ecigslaws.pdf. 
 340. Id. at 1–2. 
 341. Id. at 4–19.  
 342. The Federal Aviation Administration has banned the use of ENDS on airplanes. Use of 
Electronic, 81 Fed. Reg. 11,415 (Mar. 4, 2016) (codified at 14 C.F.R. pt. 252), available at 
https://www.gpo.gov/fdsys/pkg/FR-2016-03-04/pdf/2016-04799.pdf. That ban has been challenged by 
ENDS manufacturers. Brief for Petitioners, Competitive Enterprise Institute v. U.S. Dep’t of Transp., No. 
16-1135 (Nov. 22, 2016), available at http://casaa.org/wp-content/uploads/2016-11-22-cei-final-reply-
brief.pdf. The outcome of that case will likely inform policymakers moving forward with adding ENDS 
to clean indoor air laws. Id. 
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E. Taxation and Minimum Price Strategies  
 
 Increases in the purchase price of tobacco products can significantly reduce 
the prevalence of youth use.  Studies estimate that a 10 % increase in price will 
result in a 5-15 % reduction in overall youth consumption.343  The two primary 
methods of increasing tobacco prices are taxation and minimum price laws.344  
The Federal government, all 50 states and the District of Columbia, and hundreds 
of municipalities impose excise taxes on the sale of cigarettes and other tobacco 
products.345  Since 2002, 47 states and the District of Columbia have raised their 
cigarette excise tax rates a total of 126 times.346  Over this same time period 
reported smoking rates among U.S. high school students decreased from 22.2 to 
9.3 %.347  Minimum price laws typically establish a minimum wholesale or retail 
price under which products may not be sold.348  Originally intended to prevent 
predatory price cutting, states and localities have begun to recognize the public 
health benefit of minimum price laws.  In 2013, New York City passed the 
highest minimum price law in the country, setting the minimum legal price for a 
pack of cigarettes at $10.50.349   
 Communities have begun applying similar pricing policies to ENDS in an 
effort to reduce youth use.350  Jurisdictions may include ENDS in their definition 
 
 343. Chuck Marr & Chye-Ching Huang, Higher Tobacco Taxes Can Improve Health and Raise 
Revenue, CTR. ON BUDGET & POL’Y PRIORITIES 2 (Mar. 19, 2014), 
http://www.cbpp.org/sites/default/files/atoms/files/6-19-13tax.pdf. 
 344. See Tobacco Price Promotion: Policy Responses to Industry Price Manipulation, PUB. HEALTH 
& TOBACCO POL’Y CTR., 4, 7 (Oct. 2011), 
http://www.tobaccopolicycenter.org/documents/Price%20Promotion%20Overview%20FINAL.pdf.  
 345. Ann Boonn, State Cigarette Excise Tax Rates & Rankings, CAMPAIGN FOR TOBACCO-FREE KIDS 
(Jan. 3, 2017), available at http://www.tobaccofreekids.org/research/factsheets/pdf/0097.pdf. 
 346. Id.  
 347. See LaTisha Marshall et al., Youth Tobacco Surveillance —- United States, 2001—2002, 55 
MORBIDITY & MORTALITY WKL’Y REP. 1 (May 19, 2006),  
https://www.cdc.gov/mmwr/preview/mmwrhtml/ss5503a1.htm (stating that 22.5 % of high school 
students in 2002 reported in the National Youth Tobacco Survey that they currently smoked cigarettes); 
see also Youth and Tobacco Use, CTRS. FOR DISEASE CONTROL & PREVENTION, 
http://www.cdc.gov/tobacco/data_statistics/fact_sheets/youth_data/tobacco_use/ (last updated Apr. 14, 
2016) (stating that 9.3 % of high school students reported in 2015 that they smoked cigarettes in the past 
thirty days). 
 348. See Tobacco Control Legal Consortium, Pricing Policy: A Tobacco Control Guide, CTR. FOR 
PUB. HEALTH SYSS. SCI. 12 (2014), 
https://cphss.wustl.edu/Products/Documents/CPHSS_TCLC_2014_PricingPolicy1.pdf (explaining that 
minimum price laws typically require a minimum %age markup to be added to the wholesale and/or retail 
price of cigarettes, which results in a minimum retail price being established for the consumer). 
 349. See id. at 3; see also Tobacco Price Promotion: Policy Responses to Industry Price Manipulation, 
supra note 344 at 1. 
 350. See LEGAL RESOURCE CTR. FOR PUB. HEALTH POL’Y, 
https://www.law.umaryland.edu/programs/publichealth/documents/ENDS_50-State_Survey.pdf (last 
visited Mar. 10, 2017) (stating that states such as Louisiana and Kansas have excise taxes); see also 
Tobacco Control Legal Consortium, U.S. E-Cigarette Regulation: A 50-State Review, PUB. HEALTH & 
TOBACCO POL’Y CTR. 41, http://publichealthlawcenter.org/sites/default/files/E-Cigarette-Legal-
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of cigarettes or other tobacco products, which then subjects these products to the 
existing product tax, or separately define ENDS in the tax code.351  Alternatively, 
ENDS may be taxed based on the volume of e-liquid or the amount of nicotine.352  
Under this method accurately calculating the tax may prove difficult since e-
liquid is sold in a wide-range of sizes and nicotine concentrations.  For this 
reason, an ad valorem tax (e.g., based on the price of the product) is preferred, 
regardless of whether ENDS are incorporated into the existing definition of 
tobacco products or separately defined in the tax code.  
IX. CONCLUSION 
Because the road to federal regulation of tobacco products was long and 
arduous—and remains so—federal regulation of ENDS, just about a decade after 
the product entered the market, seems swift.353  Yet the FDA deeming rule is a 
tiny step in the scheme of regulating this ever-changing product that clearly poses 
some harm to individual and population health yet may hold some promise for 
smoking cessation. More comprehensive, sound research is needed for 
policymakers and public health officials to make the best policy decisions 
regarding the marketing, sale and use of ENDS.  As that research progresses and 
FDA begins to implement the basic provisions applicable to ENDS via the 
deeming rule, state and local governments are considering policy options to 
prevent ENDS use from increasing, particularly among youth and those who 
have never smoked cigarettes.  Using the framework of effective tobacco 
regulation and the preliminary research supporting a need for action, 








Landscape-50-State-Review-September-2016.pdf (last visited Mar. 10, 2017) (stating that Minnesota 
imposes a ninety-five % tax on the wholesale price of e-cigarettes). 
 351. See LEGAL RESOURCE CTR. FOR PUB. HEALTH POL’Y, supra note 350 (stating that e-cigarettes 
and e-juice are considered tobacco products in Minnesota and are subject to the Tobacco Tax, which is 
currently ninety-five % of the wholesale cost of any product containing or derived from tobacco).  
 352. See, e.g., KAN. STAT. ANN. § 79-3399(a) (2015) (“On and after January 1, 2017, a tax is hereby 
imposed upon the privilege of selling or dealing in electronic cigarettes in this state by any person engaged 
in business as a distributor thereof, at the rate of $.20 per milliliter of consumable material for electronic 
cigarettes and a proportionate tax at the like rate on all fractional parts thereof.”); LA. REV. STAT. ANN § 
47:841F (2017) (“Upon vapor products and electronic cigarettes, a tax of five cents per milliliter of 
consumable nicotine liquid solution or other material containing nicotine that is depleted as a vapor 
product is used.”); N.C. GEN. STAT. ANN. § 105-113.35(a1) (2016) (“An excise tax is levied on vapor 
products at the rate of five cents (5¢) per fluid milliliter of consumable product.”).  
 353. See supra Section VI (describing the decade-long legislative battle that ensued before the 
President signed into law the Family Smoking Prevention and Tobacco Control Act). 
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